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ABSTRACT 
 
ABSTRACT 
Developmental biology studies how a single cell will give rise to a fully developed, highly 
ordered and reproducible living organism. In order for this to occur, the fertilized egg 
needs to grow, divide and differentiate to produce different cell types. Subsequently, these 
different cell types need to organize into predefined arrays of committed cell groups to 
produce specialized tissues and organs, which constitute the living multicellular organism. 
Although the final product seems enormously complex, the multicellular organism is 
composed of cells that they all have the same set of genes. Cells differentiate by switching 
on and off the expression of different molecules and they produce and respond to signals 
which result in cells growing, dividing and dying in a strict spatiotemporal manner. In this 
work I aimed to address questions on the molecular mechanisms during development by 
using the fruit fly Drosophila melanogaster as a model system.  
The first aim of my studies was to characterize and investigate the role of Manf 
during Drosophila pupation and adulthood.  MANF is an evolutionarily conserved 
neurotrophic factor, which has previously been reported to protect and restore 
dopaminergic neurons in mammals. In Drosophila embryos DmMANF has been shown to 
be specifically expressed in glial populations, while DmMANF null mutants die early 
during development while they exhibit specific and significant reduction of dopaminergic 
neurites. Our data reveal that in pupae and adults, DmMANF has a much wider expression 
pattern and it is localized both in glia and neurons. This analysis led to the identification of 
an unusual phenotype in the Drosophila pupal brain. We showed when Manf is silenced, 
or either autophagy or immunity is induced in glia, macrophage-like cells appear in areas 
of the pupal brain that are normally devoid of cell bodies. We identified molecular 
markers and pathways that are activated in these cells, as well as some of the unique 
subcellular features they possess. This study brings new and elegant data in several aspects 
of glial biology with exciting perspectives for studying brain plasticity and repair. 
The second project was to characterize the expression of Gfrl receptor, the Drosophila 
homolog of the mammalian GFRα receptor in the Drosophila adult brain. The results 
showed that although the Gfrl receptor is widely expressed in the fly adult brain, this 
expression is in surprising contrast to the missing expression of dRet, the Drosophila Ret 
homolog. This data provide novel insights into further elucidation of the Ret-dependent 
and Ret-independent -GFRα signaling complexes, as well as to further understand the 
several aspects of invertebrate brain development and function. 
The third aim of this study was to investigate the role of the conserved pleiotropic 
factor Lin28 during Drosophila development. Previous studies have shown that Lin28 is 
one of the factors sufficient to reprogram human somatic cells into induced pluripotent 
stem cells. By constructing Lin-28 null mutants, our data reveal that Lin-28 mutant files 
were viable but sub-fertile, exhibiting oogenesis defects. These results will help us 
improve our understanding of Lin28 role in stem cell maintenance and differentiation. 
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REVIEW OF THE LITERATURE 
Drosophila as a model system 
As Krogh stated back in 1929 “… for a large number of problems there will be some 
animal of choice or a few such animals on which it can be most conveniently studied” 
(Krogh, 1929). This concept is central to disciplines related to biology, pharmacology and 
disease treatment, as scientists have to work with organisms, different from the ones they 
wish to apply their findings to. This is especially valid in biomedical research and its 
downstream applications that focus on the human health.  
Drosophila melanogaster, commonly referred to as fruit fly, is one of the model 
organism cornerstones of biology research. It has been used continuously for over a 
century. Attributes such as cost effectiveness, short life span, fewer ethical and legal 
constrains (compared e.g. to mouse) has rendered the fly a very convenient model 
organism for generations of scientists. This has in turn led to the generation of a broad 
arsenal of sophisticated genetic tools and web-based databases. All of the above, along 
with the extensive functional conservation to human have rendered Drosophila the 
workhorse of modern genetics. Forward genetic approaches have resulted in the 
identification of a plethora of novel genes that control complex phenomena such as cell 
division, pattern formation and programmed cell death. 
Neurobiology: the study of the nervous system 
The nervous system is a complex network of cells. It transmits signals to and from the 
brain and the spinal cord from various parts of the body. At the cellular level, the nervous 
system contains two main types of cells: (i) neurons that are long fibrous cells that 
transduce information in the form of electric potential and (ii) glia cells that are considered 
to perform mainly supportive role to neurons. In addition, a third cell type, called 
microglia, exists in the brain of vertebrates. At the anatomical level, the nervous system 
consists of two main parts: the central nervous system (CNS) and the peripheral nervous 
system (PNS) (Price et al., 2011).  
In vertebrates, the CNS is composed of the brain and the spinal cord. Invertebrate 
animals, like Drosophila, do not have a spinal cord; instead, they have an analogous 
structure that is called the ventral nerve cord (VNC). The PNS and the VNC mainly 
consist of long fibers (neurons) that connect the CNS to all parts of the body. The nervous 
system is susceptible to malfunction in a wide variety of ways, as a result of genetic 
defects, physical damage due to trauma or poison, infection or simply aging (Price et al., 
2011).  
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Neurotrophic factors in vertebrates and their classification 
Neurotrophic factors are a unique family of small, secreted proteins that provide trophic 
and survival-promoting support to neurons. The first neurotrophic factor to be identified 
was the nerve neurotrophic factor (NGF) (Levi‐Montalcini and Hamburger, 1951; Cohen 
et al., 1954), a finding that was awarded with the 1986 Nobel Prize for Physiology or 
Medicine. The classical neurotrophic factor theory is largely based on studies on NGF 
(Levi-Montalcini, 1987). The theory states that during development an excess of neurons 
is produced. These neurons are programmed to undergo apoptosis, unless they receive 
sufficient trophic support. This trophic support is provided by tissues that surround the 
neurons (glia) or the tissues that the neurons innervate (e.g. muscles) in the form of small 
secreted proteins (i.e. neurotrophic factors). Neurotrophic factors, which are usually 
secreted in limited amounts, bind to receptors on neurons and they initiate a receptor-
mediated intracellular signaling cascade resulting in halted apoptosis. Hence, only neurons 
that receive neurotrophic factors in sufficient quantities survive and maintain synaptic 
contacts, while the rest die through apoptosis. This process guarantees the correct 
matching of the number and properties of neurons to the demands of the innervated tissue 
(Levi-Montalcini, 1987). Interestingly, although mammalian neurotrophic factors have 
been studied for over 60 years and neurotrophin receptor homologs have been identified in 
organisms such as snails, mollusks and flies, no neurotrophic factors were identified in 
flies until very recently. 
In vertebrates, neurotrophic factors are classified in five main families, based on 
their amino acid sequence and structure: Glial cell-derived neurotrophic factor (GDNF) 
family ligands [reviewed in (Airaksinen and Saarma, 2002)], neurotrophins [reviewed in 
(Bartkowska et al., 2010)] and neuropoietic cytokines [reviewed in (Bauer et al., 2007) ]. 
More recent families are the MANF / Cerebral dopamine neurotrophic factor (CDNF) 
[reviewed in (Lindholm and Saarma, 2010)] and the Meteorin/Cometin family of 
neurotrophic factors (Nishino et al., 2004; Jørgensen et al., 2009; Jørgensen et al., 2012). 
Neurotrophic factors signal through transmembrane receptor tyrosine kinases (Trks) or via 
kinases that interact with their receptors [reviewed in (Bespalov and Saarma, 2007)]. Each 
family acts through its distinct receptors and activate its distinct signaling cascade; 
however, the cellular responses they elicit are often redundant. Up to date, no receptors 
have been identified for the two more recently discovered families of neurotrophic factors, 
namely the MANF/CDNF and the Meteorin/Cometin families. 
GDNF family ligands and their receptors 
The GDNF family members belong to the Transforming growth factor-β  (TGF-β) 
superfamily, containing seven cysteine residues that are conserved in their primary 
structure and determine their protein fold (Airaksinen and Saarma, 2002). Its members are 
involved in the development, differentiation and maintenance of many neuronal types 
[reviewed in (Airaksinen and Saarma, 2002)]. Its founding member GDNF was identified 
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as a neurotrophic factor that promotes the survival and differentiation of dopaminergic 
neurons in vitro (Lin et al., 1993). GDNF has regenerative properties and along with 
BDNF (Brain-derived neurotrophic factor) and neurturin, they are the only neurotrophic 
factors used in clinical trials as a potential treatment for Parkinson’s disease [reviewed in 
(Vastag, 2010)]. Other members of this family include neurturin (Kotzbauer et al., 1996), 
artemin (Baloh et al., 1998) and persephin (Milbrandt et al., 1998). The GDNF family 
ligands are secreted as pre-pro-proteins, which need to be cleaved and homodimerize in 
order to be functional. They signal through a heteromeric signaling complex composed of 
the transmembrane Trk receptor Ret and a class of co-receptor subunits [GDNF receptor 
(GFR) α subunits 1 to 4], which are linked to the plasma membrane by a glycosyl 
phosphatidylinositol (GPI) anchor (Treanor et al., 1996) (Figure 1A). The GFRα subunits 
confer the ligand specificity: GDNF binds to GFRα1, neurturin to GFRα2, artemin to 
GFRα3 and persephin to GFRα4, although weak crosstalk has also been documented 
(Airaksinen and Saarma, 2002). 
MANF / CDNF family 
The Mesencephalic astrocyte-derived neurotrophic factor (MANF) is the founding 
member of this neurotrophic factor family, which consists of two members. MANF was 
initially discovered as a gene mutated in renal cell carcinomas and named ARMET 
(Argenine Rich Mutated in Early Stage Tumours) or ARP (Arginine Rich Protein) 
(Shridhar et al., 1996). However, later studies showed that the polymorphisms attributed 
to ARP’s tumorigenic function were also seen in normal tissue (Evron et al., 1997; Tanaka 
et al., 2000; Piepoli et al., 2006). Later ARP was identified as a novel factor that supports 
dopaminergic neurons in vitro and was renamed MANF (Petrova et al., 2003). Subsequent 
bioinformatic and biochemical studies identified a paralog to MANF called CDNF 
(Lindholm et al., 2007). MANF and CDNF comprise a novel family that is structurally 
unrelated to classical neurotrophic factors and growth factors (Lindholm and Saarma,  
 
 
Figure 1. Neurotrophic factors in vertebrates and their Drosophila homologs. (A) In 
vertebrates, the dimer of GDNF ligand binds to the co-receptor GFRα and the GDNF-
GFRα complex will activate the transmembrane receptor Ret. In flies, a Ret receptor 
(Hahn and Bishop, 2001) and a GFRα (Kallijärvi et al., 2012) receptor homolog have 
been identified. The ligand for either Gfrl or dRet has not been identified in flies. (B) 
Schematic presentation of the primary structures of Drosophila Manf (DmMANF) and 
the human MANF and CDNF proteins. In all MANF family proteins, the spacing of the 8 
cysteines (as indicated by dotted lines) is strictly conserved. (C) Schematic presentation 
of the primary structure of Drosophila DNT1 and human members of the neurotrophin 
family proteins. Although the six-cysteine residues are conserved, the spacing (as 
indicated by dotted lines) differs even between neurotrophin members that derive from 
the same species. (D and E) No Drosophila homologs of the neurokine and the 
Meteorin/Cometin families have been identified. 
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2010). They contain a secretion signal, but no pro-sequence, suggesting that they do not 
need to be enzymatically processed in order to become active. In addition, MANF and 
CDNF contain eight cysteine residues that are conserved in their primary structure 
(Shridhar et al., 1996; Petrova et al., 2003; Voutilainen et al., 2009) (Figure 1B).  
Both MANF and CDNF were shown to specifically protect and restore 
dopaminergic neurons in rat (Lindholm et al., 2007; Voutilainen et al., 2009) and mouse 
(Airavaara et al., 2012) models of Parkinson’s disease. Because the MANF/CDNF class of 
neurotrophic factors is structurally unrelated to previously identified neurotrophic factors, 
it is anticipated that it also activates distinct signaling mechanisms, compared to other 
neurotrophic factors (Lindholm and Saarma, 2010). This renders MANF protein an 
interesting molecule that can potentially lead to novel treatments of neurodegenerative 
diseases, and most importantly, Parkinson’s disease.  
According to crystal structure studies, the mature human MANF and CDNF consist 
of two domains: (i) a saposin-like N-terminal domain which may bind to lipids or 
membranes and (ii) a C-terminal domain, similar to that of thiol/disulphide 
oxidoreductases and isomerases which suggests that MANF and CDNF may be involved 
in protein folding in the endoplasmic reticulum (ER) (Parkash et al., 2009). On the 
molecular level, no upstream or downstream targets for MANF have been identified up to 
date. Recently however, it has been shown that MANF binds intracellularly to the KDEL 
receptor in the ER (Glembotski et al., 2012) and several lines of evidence point towards 
MANF having both extracellular and intracellular functions. From these, the best studied 
is its role as an ER stress-responsible protein (Apostolou et al., 2008; Palgi et al., 2012). 
Both MANF and CDNF are expressed during all developmental stages in a variety 
of neuronal and non-neuronal tissues (Lindholm et al., 2007; Lindholm et al., 2008), a 
common feature for all neurotrophic factors. This expression in non-neuronal tissues 
suggests that they have a role outside the nervous system. In fact, it has recently been 
shown and that MANF protects cardiac myocytes in myocardial infraction (Glembotski et 
al., 2012) and that MANF deficiency results in pancreatic β cell depletion and diabetes  in 
mice (Lindahl et al., 2014). In the brain, both CDNF and MANF are relatively widely 
expressed and are localized in neuronal populations such as cerebellar Purkinje cells 
(Lindholm et al., 2008). MANF but not CDNF has also been shown to be expressed in 
tyrosine hydroxylase (TH) positive neurons (Lindholm et al., 2008), while neither CDNF 
nor Manf is expressed in glial cells in mice (Lindholm et al., 2008). In addition, MANF is 
strongly expressed in embryonic salivary glands, pancreas, and in adult liver, heart, and 
testis and more specifically in the early spermatocytes (Lindholm et al., 2008). On the 
other hand, CDNF is also expressed in the heart, testis, but unlike MANF, it is strongly 
expressed in skeletal muscle of adult mice (Lindholm et al., 2007). 
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Neurotrophins 
The term neurotrophin is often used as a synonym for neurotrophic factor. However, it is 
generally accepted that neurotrophin specifically refers to four structurally related factors: 
NGF (Levi‐Montalcini and Hamburger, 1951), BDNF (Barde et al., 1982; Leibrock et al., 
1989), neurotrophin-3 (Hohn et al., 1990) and neurotrophin-4/5 (Berkemeier et al., 1991; 
Hallböök et al., 1991) [reviewed in (Bartkowska et al., 2010)]. Neurotrophins are 
synthesized as large precursors that are cleaved to release the mature and active form. The 
mature neurotrophins are 12 to 14 kDa in size and bear six cysteine residues, allowing 
them to form three disulphide bridges, which collectively form a protein structural motif 
known as cysteine knot (Figure 1C). One end of the molecule contains a cysteine-knot, 
which stabilizes the fold and locks the molecule to its specific conformation (Wiesmann et 
al., 1999; Wiesmann and De Vos, 2001), while the other end has three hairpin loops that 
are responsible for the functional differences between the proteins of the neurotrophin 
families (McDonald et al., 1991). Neurotrophins form homodimers and mediate their 
action through two classes of receptors, high- and low- affinity receptors. The low affinity 
receptor (p75NTR) enhances the binding of neurotrophins to the high affinity receptors. The 
high affinity receptors are members of the Trk superfamily. 
Neurokines 
Neurokines, also known as Ciliary neurotrophic factor (CNTF) family after its most 
prominent member, also include interleukin-6, cardiotropin -1 and -2 and leukemia 
inhibitory factor (LIF). Members belonging to this category of neurotrophic factors are 
structurally similar to cytokines. They signal through cytokine receptors and activate the 
JAK-STAT and MAPK signal transduction pathways. Neurokines are mostly known for 
their role in the control of neuronal, glial and immune responses to injury and disease, as 
well as for their role in regulation of neurogenesis [reviewed in (Bauer et al., 2007)].  
Meteorin / Cometin family of neurotrophic factors 
Meteorin (Nishino et al., 2004; Jørgensen et al., 2009) and Cometin (Jørgensen et al., 
2012) constitute the most recently described family of neurotrophic factors. Although little 
is known about their mechanism of action, data indicate that signal through the 
JAK/STAT and MAPK pathways (Jørgensen et al., 2009; Jørgensen et al., 2012). 
Interestingly, Cometin is only expressed during development and not in adult animals.  
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Neurotrophic factors in invertebrates 
Direct neuron-glia interactions and secretion factors that control proper nervous system 
development and function are well established in Drosophila [for review see (Silies and 
Klämbt, 2011)]. In addition, molecules secreted from axons have been shown to be 
required for glial survival. Such molecules include the Drosophila Neuregulin homolog 
Vein (Hidalgo et al., 2001) and the TGF-like ligand spitz (Hidalgo et al., 2001; Bergmann 
et al., 2002). However, no neurotrophic factors in invertebrates i.e. secreted factors that 
control the number, the survival and they provide trophic support to neurons, were 
identified until very recently. 
Several lines of evidence support the existence of neurotrophic factors in 
Drosophila. Fly neurons are produced in excess and surplus is removed by programmed 
cell death (PCD) during development (White et al., 1994). In addition, it has been shown 
that in the Drosophila visual system, local absence of glia is accompanied by extensive 
apoptosis of neurons (Dearborn and Kunes, 2004); however, these signals are still 
unknown.  
The first direct indication for the existence of neurotrophic factors in invertebrates 
came from the in silico identification (Sugaya et al., 1994) and subsequent cloning (Hahn 
and Bishop, 2001) of the Drosophila Ret (dRet), the receptor of the GDNF family of 
neurotrophic factors. Interestingly, dRet is expressed in the nervous and digestive system, 
expression pattern that it is in accordance to the mammalian Ret expression (Hahn and 
Bishop, 2001). Furthermore, chimeric receptors composed from the human extracellular 
Ret domain and the Drosophila intracellular dRet domain, respond to human GDNF 
(Abrescia et al., 2005), therefore suggesting a degree of functional conservation. However, 
up to date, no ligands have been identified for dRet and therefore its possible neurotrophic 
role has not been demonstrated (Sugaya et al., 1994; Hahn and Bishop, 2001). In addition, 
no homologs of the GDNF family ligands, the cytokine family ligands or the 
Meteorin/Cometin family appear to be encoded in the Drosophila genome or in other 
invertebrates (Airaksinen et al., 2006), possibly due to low amino acid sequence 
conservation. 
Recently however, and greatly due to the number of animal whole sequencing data 
and the better performance of search algorithms in identifying sequence and structural 
homologies, molecules with neurotrophic factor properties in Drosophila have started to 
emerge. To date, two Drosophila neurotrophic factor families have been discovered, both 
of which share homologies to mammalian neurotrophic factors. 
Drosophila Neurotrophins (DNTs) 
Spätzle and its receptor Toll were originally identified in screens detecting genes required 
for the dorsoventral axis formation of Drosophila embryos (Anderson et al., 1985). 
Spätzle, like neurotrophins, was shown to be secreted in an inactive form that upon 
cleavage and homodimerisation can exert its function (DeLotto and DeLotto, 1998; 
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Ligoxygakis et al., 2002; Weber et al., 2003; Hu et al., 2004). In addition, structural and 
biophysical data indicate that Spätzle has a cysteine knot domain that is very similar to the 
cystein knot of neurotrophins (DeLotto and DeLotto, 1998; Mizuguchi et al., 1998; 
Hoffmann et al., 2008). However, the overall sequence homology between Spätzle and 
neurotrophins is very low and hence Spätzle has not been considered as relevant to the 
neurotrophin superfamily. It was not until very recently that it was shown conclusively 
that Spätzle, along with two paralog proteins, namely DNT1 and DNT2, have 
neurotrophic properties in flies and belong to the neurotrophin family of neurotrophic 
factors that is evolutionarily conserved among protostomes and deuterostomes (Zhu et al., 
2008) (Figure 1C). Interestingly, there are no canonical homologs of the mammalian 
neurotrophin receptors in flies. However, it was recently demonstrated that Toll receptors 
are mechanistically similar to vertebrate NTRs and DNT1 and DNT2 bind to Toll-7 and 
Toll-6 respectively, to exert their neurotrophic functions (McIlroy et al., 2013). In 
addition, crystallographic data show that the molecular structure of Spätzle/Toll complex 
is strikingly similar to NGF in complex to p75NTR (neurotrophin receptor) (Lewis et al., 
2013). 
Drosophila MANF (DmMANF) 
Sequence analysis among species also revealed a second neurotrophic factor, DmMANF, 
as homolog of the mammalian MANF/CDNF family of neurotrophic factors (Palgi et al., 
2009). DmMANF shares a striking 50% and 47% amino acid sequence identity with 
human MANF and CDNF, respectively (Palgi et al., 2009; Lindholm and Saarma, 2010). 
In addition, the spacing between the characteristic eight-cysteine residues is strictly 
conserved (Figure 1B).  
DmMANF, as its mammalian homologs, is also secreted (Palgi et al., 2009). It is 
maternally contributed to embryos and it is expressed widely in many tissues during 
embryogenesis and larval stages. In the embryonic and larval CNS, DmMANF is 
expressed specifically in the cell body glia that surround the TH-positive midline neurons. 
This subpopulation of glia also express the transcription factor eagle and it is identified as 
a glial subpopulation that is related to the mammalian astrocytes (Ito et al., 1995; Palgi et 
al., 2009). In addition, DmMANF is also found in longitudinal glia that express the 
transcription factor prospero (Palgi et al., 2009). In embryos, DmMANF does not co-
localize with neuronal markers (Palgi et al., 2009). 
DmMANF is also highly expressed in many non-neuronal tissues that have a high 
secretory activity. In addition to being expressed in the CNS during embryogenesis, 
DmMANF is predominantly expressed in garland cells (Palgi et al., 2012), which are 
highly endo- exo-cytotic cells showing structural similarities to mammalian kidney 
podocytes. The role of garland cells is to form a barrier and filtrate the hemolymph 
(Weavers et al., 2008). Other secretory tissues where DmMANF is expressed during 
embryogenesis and larval stages are salivary glands, Malpighian tubules, fat body, trachea 
(http://flyatlas.gla.ac.uk) and ovarian follicle cells (Palgi et al., 2009; Palgi et al., 2012). 
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DmManf null mutants die as early second instar larvae and exhibit specific and 
significant reduction of dopaminergic neurites, while other neuronal cell populations seem 
unaffected (Palgi et al., 2009). Interestingly, the fly null phenotype can be rescued by the 
human MANF (Palgi et al., 2009) and CDNF (Lindström et al., 2013), suggesting that the 
human and the fly MANF proteins are functionally orthologous and therefore 
evolutionarily conserved.  
Glia 
Glia are abundant cells in the brain of animals including flies and humans. For long, they 
were thought to have mainly supportive roles. However, this notion is changing as new 
findings demonstrate that glia cells play an irreplaceable role in all aspects of brain 
development and function [e.g. insight issue in Nature edited by (Chouard and Gray, 
2010)]. In the fly, glia, as well as neurons, derive from neuroblasts. Early glia cells express 
transiently the transcription factor glial cells missing (gcm), which turns on the 
homeodomain gene reverse polarity (Repo). Repo is required for glia differentiation and it 
is expressed in all glia during both development and adulthood. The only exception is a 
group of glia cells, namely midline glia, that do not express Repo, but express gcm. 
Interestingly, midline glia are eliminated during pupal stage and do not exist in adult flies 
(Rusconi et al., 2000). Elimination of midline glia occurs through apoptosis and is the 
result of elevated ecdysone levels during pupation (Rusconi et al., 2000). In addition to 
regulating the expression of glial genes, Gcm also regulates the expression of genes such 
as draper (Freeman et al., 2003), which are expressed in macrophages.  
Different classes of Drosophila glia have been characterized, which share many 
morphological, functional and molecular similarities with their mammalian counterparts 
(Barres, 2008; Klämbt, 2009; Hartenstein, 2011). Glia in flies perform versatile functions, 
including pathfinding and enseathing of axons, they form the blood brain barrier 
[reviewed in (Edwards and Meinertzhagen, 2010)] and provide trophic support for neurons 
(Booth et al., 2000). Interestingly, flies do not have a “professional” resident macrophage 
glial cell type, similar to mammalian microglia in the vertebrate nervous system. 
Microglia –The macrophages of the vertebrate nervous system 
Macrophages are highly specialized cells that constitute the cellular immunity of 
organisms including flies and humans (see later). In mammals, resident macrophages exist 
in all tissues of the body and are the first line of defense against injury and infection, 
responding rapidly to disturbances in tissue homeostasis. The resident macrophages of the 
mammalian nervous system are called microglia. Microglia belong to the glial system of 
non-neuronal cells and they are broadly distributed throughout the brain and spinal cord 
(Lawson et al., 1990). They constitute about 10% of the total CNS cell population (Hugh 
Perry, 1998; Mittelbronn et al., 2001).  
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Unlike macrophages, which are short-lived and regularly regenerated throughout life 
from cells in the bone marrow, microglia are long-lived cells – essentially the whole 
lifespan of the organism. They derive from primitive myeloid progenitors that originate 
from the extra-embryonic yolk sac (Ginhoux et al., 2010). They enter the nervous system 
where they proliferated and undergo a profound structural and physiological remodeling to 
differentiate into microglia cells (Ginhoux et al., 2010). In essence, microglia are the first 
glial cell population (4.5 weeks gestation for humans) and enter the nervous system before 
the formation of the blood-brain barrier, which prevents cells (including immune cells) to 
enter the nervous system. Therefore the initial microglial population that is formed during 
embryogenesis is the same found in adult animals. Local cell division that maintains the 
microglial number has been observed in rodents, but it is at a very low rate (Lawson et al., 
1992).  
Microglia have two main functional aspects: CNS maintenance and immune 
defense. Under physiological conditions, microglia are found in a “resting” state; they 
have a small cell body and multiple thin processes that extend in all directions and which 
continuously scan the environment for changes in brain homeostasis. Upon a brain insult, 
microglia are “activated”: they change their morphology to an amoeboid form, retract their 
processes and start upregulating a variety of cell-surface and cytoplasmic molecules, 
including neurotrophic factors, tumor necrosis factors (TNFs), Toll-like receptors (TLRs), 
pro-inflammatory mediators and immune response molecules (Rivest, 2009; Perry et al., 
2010; Kettenmann et al., 2013). They also become motile and move towards the injury. 
Under special conditions (e.g. cell death in the CNS), microglia transform further and 
become phagocytotic. Thus, microglia can produce their effect either through 
phagocytosis or through secreting various factors with trophic, neuroprotective and 
transmitter properties (Perry et al., 2010). The nature of the signal that triggers the process 
of microglia activation is not fully understood, but it can be both due to endogenous and 
exogenous stimuli [reviewed in (Kierdorf and Prinz, 2013)]. 
Microglia are activated when the brain homeostasis is disturbed. Virtually, all 
mammalian brain pathologies are accompanied by activation of microglia, including 
infections and inflammation. In addition, in CNS tissues from patients with chronic 
neurodegenerative diseases like Parkinson's disease and prion disease, active microglia are 
always present in large numbers (Perry et al., 2010). Microglia also have an active role 
during development and adult circuit plasticity and function [reviewed in (Tremblay et al., 
2011)]. 
Immunity in Drosophila 
Immunity is the ability of an organism to resist infection and disease through its immune 
system. The immune system has two main functions: to recognize invading pathogens and 
then trigger pathways that will destroy them. Immunity is divided into innate and adaptive 
immunity based on the specificity of the response towards the pathogen. Innate immunity 
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is the first and most ancient line of defense against pathogens. It provides resistance to a 
wide range of pathogens through means of non-specific response such as phagocytosis 
(cellular immunity) and secretion of antimicrobial peptides, through activation of NF-κb 
pathways (humoral immunity). Antimicrobial peptides are an evolutionarily conserved 
component of the innate immune response found in all animals and plants and represent 
the main form of invertebrate systemic immunity. On the other hand, in adaptive 
immunity, the response is “custom made” to the pathogen through specific antigen – 
antibody recognition. 
Although it is commonly accepted that Drosophila has only innate immunity, this 
notion is under challenge as new studies show that Drosophila has a primitive form of 
adaptive immunity (Watson et al., 2005; Dong et al., 2006). In addition, Drosophila has 
retained RNA interference (RNAi) as a potent antiviral pathway, in contrast to mammals 
that have probably lost this ability (Sabin et al., 2010). 
Cellular immune response  
As in humans, the Drosophila cellular immune response is elicited by leukocyte-like cells, 
which are known as hemocytes [reviewed in (Wood and Jacinto, 2007; Ulvila et al., 
2011)]. Hemocytes are found in the hemolymph (blood) of the fly where they either 
circulate freely, or they are associated with various tissues and organs. Apart from 
constituting the cellular immune response during pathological conditions, hemocytes are 
also responsible for phagocytosis of apoptotic cells during embryogenesis as well as 
during organ remodeling during metamorphosis (Abrams et al., 1993; Tepass et al., 1994; 
Franc et al., 1996). The Drosophila hemocyte population is divided into three classes: 
plasmatocytes, crystal cells and lamellocytes, which appear in two different hematopoietic 
waves during Drosophila development (Figure 2). From these three hemocyte 
populations, plasmatocytes are the most abundant, constituting 95% of the embryonic 
hemocyte population. Interestingly, hemocytes of embryonic origin persist to adulthood 
(Figure 2).  
Of special importance, is that after the sealing of ventral nerve cord at 20 hours of 
development (Schwabe et al., 2005) and the formation of the blood brain barrier, 
hemocytes surround the ventral nerve cord without entering it (Kurant et al., 2008). 
Hemocytes have not been identified in the nervous system. Instead glia assume a semi-
professional phagocytotic role, a function that is strongly reflected on the molecular level 
by a strong differential expression of phagocytosis genes in glia (Kurant et al., 2008).  
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Humoral immune response  
NF-κb family members are an evolutionarily conserved class of transcription factors. They 
regulate numerous fundamental biological processes, among which is the control of the 
expression of genes encoding anti-microbial peptides. NF-κb proteins are found inactive 
in the cytoplasm. Upon stimulation, they are activated either by proteolytic cleavage or by 
degradation of their corresponding inhibitory protein and subsequent release. 
Consequently, they translocate to the nucleus to control the transcription of immune 
responsive genes (Hetru and Hoffmann, 2009; Sabin et al., 2010; Ganesan et al., 2011; 
Kounatidis and Ligoxygakis, 2012).  
In flies, three NF-κb proteins, namely Dif, Dorsal and Relish, control almost half of 
the immune responsive genes (Ganesan et al., 2011). Two well-characterized NF-κb 
pathways control antimicrobial peptide gene expression in Drosophila: the Toll and the 
Immune deficiency (Imd) pathways. In both cases, peptidoglycans (PGN) on the 
pathogens cell walls are recognized by pattern recognition receptors (PRRs). The latter are 
activated and consequently activate NF-κb transcription factors, which in turn translocate 
to the nucleus to induce an anti-microbial program (Figure 3). The Drosophila Toll 
pathway shares similarities with the invertebrate Interleukin-1 and the Toll-like receptor 
pathways, while the Imd pathway is homologous to the TNF pathway (Hetru and 
Hoffmann, 2009; Sabin et al., 2010; Ganesan et al., 2011; Kounatidis and Ligoxygakis, 
2012).  
Toll pathway  
The Toll pathway is activated by Gram-positive bacteria and fungi, which are initially, 
recognized by peptidoglycan recognition proteins (PGRPs) and glucan-binding proteins 
Figure 2. Hemocyte specification 
in Drosophila. Embryonic 
hemocytes arise in the procephalic 
mesoderm in early embryogenesis, 
while lymph gland hemocytes 
derive later in development from 
cardiogenic mesoderm. Both 
embryonic and lymph gland 
hemocytes contribute to the 
hemocyte population of the pupae 
and adults. Image modified from 
(Wood and Jacinto 2007). 
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(Hetru and Hoffmann, 2009). The latter initiate a cascade that results in the activation of 
the cytokine Spätzle, which in turn activates the transmembrane receptor Toll (Hetru and 
Hoffmann, 2009; Kounatidis and Ligoxygakis, 2012). The activation of Toll results in the 
phosphorylation of Cactus, which is targeted for degradation. Upon Cactus degradation, 
the NF-κb members Dif and Dorsal are translocated to the cell nucleus, where they act as 
transcription factors controling the expression of genes encoding immune-responsive 
peptides (Hetru and Hoffmann, 2009; Kounatidis and Ligoxygakis, 2012). 
 
 
 
 
 
Figure 3. Comparison of the mammalian and the fly humoral immunity. In both 
flies and mammals, a receptor is activated and transduces its signal to the effector 
molecule that is an NF-κb molecule. The NF-κb molecule will be translocated into the 
nucleus where it will activate immune responsive genes. In flies, the Toll pathway will 
activate dorsal, while the Imd pathway will activate the transcription factor Relish. 
Imd pathway 
The Imd pathway is activated by diaminopimelic acid containing PGNs, commonly found 
on the cell walls of Gram-negative bacteria. These molecules bind to two PGN family 
members, PGRP-LC and PGRP-LE, activation of which leads to nuclear translocation of 
the NF-κB factor Relish (Hetru and Hoffmann, 2009; Kounatidis and Ligoxygakis, 2012). 
Upon immune challenge, Relish is cleaved so its N-terminal fragment to translocate to the 
nucleus and it acts as a transcription factor to activate immune-responsive peptides, while 
its C-terminal fragment remains in the cytoplasm (Stöven et al., 2000). Cleavage per se 
however, is not sufficient for Relish translocation (Kleino et al., 2005). Recently, it has 
been reported nuclear localization of the C-terminal fragment of Relish (Tapadia and 
Verma, 2012).  
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Immunity in the Drosophila brain 
In comparison to vertebrates brains where microglia are the dedicated immune system, in 
the fly, no microglia or microglia-like cells have been identified. During both development 
and adulthood, sessile glia assume a semi-professional immune role which is critical for 
the elimination of superfluous or damaged cells through PCD and against brain 
homeostasis disturbances. Glia have been shown to be the main phagocytes in fly embryos 
(Freeman et al., 2003; Kurant et al., 2008) and their role has been studied in apoptotic 
clearance and axon pruning during metamorphosis (Awasaki and Ito, 2004; Dekkers et al., 
2013) and after neural injury in adult flies (MacDonald et al., 2006). 
Microglia-like cells have been identified in mollusks (Stefano et al., 1996), annelids 
(Elliot and Muller, 1981) and have been shown to appear under in vitro conditions in 
cockroaches (Sonetti et al., 1994). Drosophila has macrophages (hemocytes) that display 
phagocytotic and scavenger properties and perform apoptotic clearance during 
embryogenesis (Sonnenfeld and Jacobs, 1995). However, once the nerve cord is enseathed 
and the blood-brain barrier is formed, hemocytes no longer have access to the nervous 
system (Kurant et al., 2008) and no other professional immune cell type has been 
identified in Drosophila brain (Edwards and Meinertzhagen, 2010).  
Autophagy 
Autophagy is a secondary ancient and evolutionarily conserved defense mechanism that 
organisms use to eliminate pathogens (Yano et al., 2008; Levine et al., 2011). It occurs 
independently of the Toll and Imd innate signaling pathways. Autophagy is the catabolic 
mechanism that involves the degradation of a cell’s own components via the lysosomal 
machinery. Eukaryotic cells have evolved this self-cannibalization process as a means to 
maintain cellular homeostasis during unfavorable conditions. Autophagy is induced under 
stress conditions, such as starvation, hypoxia, heat and drug treatment. It is well 
characterized and requires more than 20 autophagy (atg) genes (Xie and Klionsky, 2007). 
Autophagy has been implicated as a means of PCD, called autophagic cell death or 
type II PCD, in contrast to apoptosis (type I PCD) (Schweichel and Merker, 1973). 
Although this notion is under great debate, recent studies, argue that at least in 
Drosophila, autophagy acts as a mean of PCD, both in stress situations (Berry and 
Baehrecke, 2007) as well as during normal development (McPhee et al., 2010). Notably, 
in Drosophila the engulfment receptor Draper has been demonstrated to be autonomously 
required for autophagy associated with cell death, while it is not required for autophagy 
associated with cell survival (McPhee et al., 2010). 
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Oogenesis 
The egg is the largest cell in all animals, conversely with the other germ cell, the sperm, 
which is usually the smallest cell (Alberts et al., 1994). The human egg is visible by the 
naked eye and it is 1000 times larger than a typical somatic cell. The enormous size of the 
egg is due to the fact that the egg needs to store large amounts of messenger RNA 
(mRNA) and proteins that are needed for oogenesis, fertilization and development 
(Alberts et al., 1994). This is especially true for animals like Drosophila, which do not 
have a placenta and their oocyte is transcriptionally inactive (Alberts et al., 1994). 
In Drosophila, eggs are continuously produced from stem cell populations, resulting 
in an independent array of egg chambers, known as ovariole [oogenesis reviewed in 
(Spradling, 1993)]. Each ovary is composed of several ovarioles, which all have the same 
anterior-posterior direction (Figure 4A). The anterior-most egg chamber, the germarium, 
houses two stem cell populations: the germline stem cells (GSCs) and the follicular stem 
cells (FSCs). In each germarium there are two or three GSCs (Figure 4A and 4B). The 
GSC divides asymmetrically to produce another stem cell and a cystoblast. Cystoblasts 
undergo four mitotic divisions with incomplete cytokinesis to form a cluster of 16 cells 
(cystocytes), which are interconnected with cytoplasmic bridges called ring canals (Figure 
4C). Of the 16 cystocytes, only one will become the oocyte, while the other 15 will 
Figure 4. Drosophila oogenesis. (A) Schematic drawing of an ovariole with 
germarium at the anterior tip and egg chambers of increasing age. The egg chamber 
consists of three main cell types. The germ line derived oocyte, its endopolyploid 
sister cells called nurse cells and the follicle cells, which are of somatic origin. (B) 
Magnified view of germarium. Cap cells in pink and spectrosome/fusome in red (C) 
GSCs divide asymmetrically to give rise to a cystoblast and a GSC. The cystoblast 
will divide four times with incomplete cytokinesis to produce 16 cystocytes. 
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become the nurse cells. The oocyte is always the posterior-most cell in the egg chamber 
(Figure 4A) and retains a proteinaceous organelle, the fusome, which was present in the 
original cystoblast. Germ cells and cystoblasts contain a spherical cytoplasmic structure 
called the spectrosome, which develops into a branched fusome that transverses the 
intercellular ring canals, linking the cytoplasm of individual cystocytes. The fusome will 
disappear after the last mitotic division (Figure 4B). 
Oogenesis in Drosophila has been divided into 14 stages. During stage 9, the follicle 
cells migrate towards the oocyte, leaving only very few cells at the anterior of the egg 
chamber. At stage 10, a group of anterior follicle cells called border cells, will start to 
migrate towards the anterior of the oocyte through the nurse cells. This migration is 
crucial for the formation of the micropyle, which is needed for the egg fertilization.  
During oogenesis, the nurse cells are transcriptionally very active. This is 
pronounced by the large and highly polyploid nurse cell nuclei, compared to the nucleus 
of the transcriptionally inactive oocyte nucleus that is called the karyosome.  Nurse cells 
produce large amounts of RNA and proteins that are consequently transported to the 
oocyte through the ring canals, while the follicle cells secrete the vitelline membrane and 
the chorion. 
Lin-28 and let-7 
Lin-28 is an evolutionarily conserved RNA-binding molecule that gained ample attention 
after it was identified to be one of the reprogramming factors used to induce pluripotency 
in adult human fibroblast cells (Yu et al., 2007). Lin-28 is unique among the 
reprogramming factors as it is the only RNA binding protein, rather than a transcription 
factor. Initially, lin-28 was discovered in a C. elegans screen for heterochronic genes that 
control developmental timing (Ambros and Horvitz, 1984). In C. elegans Lin-28 is 
expressed broadly during the first larval stage and subsequently its levels are reduced 
during the second and is greatly diminished by the third and fourth larval stages (Moss et 
al., 1997). Lin-28 downregulation is mediated by two miRNAs, namely let-7 and lin-4 
(Moss et al., 1997). lin-28 homologs exist in all bilaterian animals ranging from flies to 
humans, indicating an ancient origin of this gene (Moss and Tang, 2003). All homologs 
are composed of four domains, a positively charged linker that binds three RNA-biding 
motifs: two Cys-Cys-His-Cys (CCHC)-type zinc-binding motifs and a cold shock domain 
(CSD) (Moss and Tang, 2003). Interestingly, all homologs have conserved let-7 binding 
domains, indicating that lin-28 is regulated by let-7 (Moss and Tang, 2003). Subsequently, 
lin-28 mRNA was shown to be a conserved target of the let-7 miRNA family both in C. 
elegans and in higher vertebrates (Reinhart et al., 2000; Yang and Moss, 2003). On the 
other hand, Lin-28 was found to inhibit let-7 processing (Viswanathan et al., 2008), by 
physically interacting with the let-7 precursor, and therefore preventing further processing 
towards the mature let-7 form (Newman et al., 2008; Loughlin et al., 2011). Further 
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studies heavily concentrated on the double-negative feedback loop between these two 
pivotal molecules, Lin-28 and let-7. 
let-7 was also identified in a screen for heterochronic genes that control 
developmental timing in C. elegans (Reinhart et al., 2000). It was one of the first two 
known miRNAs (Ambros, 2001) and the first miRNA to be discovered in humans 
(Pasquinelli et al., 2000). let-7 miRNA is also evolutionarily conserved in all bilaterians 
and from flies to humans in both sequence and function and is expressed in a similar 
temporal pattern in diverse species (Pasquinelli et al., 2000). Targets of let-7, apart from 
Lin-28, are the oncogenes RAS (Johnson et al., 2005; Kumar et al., 2008), KRAS (Chin et 
al., 2008), HMGA2 (Mayr et al., 2007) and c-myc (Sampson et al., 2007). Interestingly, 
let-7 was found to have an expression that is reciprocal to Lin-28 expression in various 
contexts. In mice and humans, Lin-28 is highly expressed in embryonic stem cells (ESCs), 
but its downregulated in most differentiated adult tissues; on the other hand, let-7 levels 
are not detectable in ESC, but its levels increase upon differentiation and are maintained in 
adult tissues [(Sempere et al., 2004; Thomson et al., 2004; Schulman et al., 2005; 
Wulczyn et al., 2007; Van Wynsberghe et al., 2011) and reviewed in (Viswanathan and 
Daley, 2010)].  
Subsequently, the role and relationship between Lin-28 and let-7 has been 
extensively studied in relevance to cancer in a broad range of cancer types, including 
ovarian, prostate, colon, lung, epithelial and breast cancers among others [see reviews 
(Boyerinas et al., 2010; Huang, 2012; Zhou et al., 2013)]. Their relationship during 
tumorigenesis reflects their reverse relationship during embryogenesis. Lin-28 is largely 
seen as a powerful regulator of stem cell and germ cell self-renewal, while let-7 is 
associated with progression of differentiation (Oishi and Wang, 2011) (Figure 5). As a 
result, both molecules are explored as potential biomarkers (prognostic markers) and 
theurapeutic targets in cancer research [see reviews (Boyerinas et al., 2010; Huang, 2012; 
Zhou et al., 2013)]. 
Recent data indicate that Lin-28 has also a let-7 independent mechanism of action 
and plays an important role in translational regulation. A recent genome-wide association 
study revealed that in human ES and somatic cells Lin-28 target more than 6,000 genes, 
through a GGAGA binding motif (Wilbert et al., 2012), indicating that Lin-28 plays a 
prominent role in post-transcriptional regulation. In addition, other studies have 
demonstrated that Lin-28 directly interacts with and regulates the production of histone 
H2a (Xu and Huang, 2009), Cyclin A, Cyclin B and Cyclin-dependent kinase 4 (Xu et al., 
2009) and IGF-2 (Polesskaya et al., 2007). Interestingly, Lin-28 has also been shown to 
bind and regulate Oct4 mRNA (but not NANOG or SOX2) (Qiu et al., 2010).  
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In Drosophila, two independent let-7 null mutants have been created (Caygill and 
Johnston, 2008; Sokol et al., 2008). Surprisingly, let-7 null mutant animals are viable and 
fertile. However, they exhibit multiple defects, including defects in maturation of the 
neuromuscular junctions (Caygill and Johnston, 2008; Sokol et al., 2008), and late-
neurons (Kucherenko et al., 2012). In addition, they exert reduced fecundity (Caygill and 
Johnston, 2008; Sokol et al., 2008) and defects in the stem cell maintenance in testis 
(Toledano et al., 2012). On the molecular level, let-7 is activated by the steroid hormone 
ecdysone (Chawla and Sokol, 2012), while it regulates the transcription factors abrupt 
(Caygill and Johnston, 2008) and chimno (Wu et al., 2012), the adhesion molecule 
Fasciclin 2 (Kucherenko et al., 2012) and the RNA binding protein Imp (Toledano et al., 
2012). 
 
Figure 5. Lin-28 is highly 
expressed in stem cells, while let-
7 in differentiated cells. Lin-28 
blocks let-7 miRNA maturation. 
As stem cells differentiate, Lin-28 
expression decreases, which allows 
let-7 processing and increased 
production of mature let-7. Image 
modified from (Oishi and Wang 
2011). 
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AIMS OF THE STUDY 
In this thesis I addressed questions from a wide spectrum of Drosophila development. The 
general aims of this study were: 
 
• To study the expression pattern of the GDNF receptor alpha homolog (GFRl) in 
the Drosophila adult brain 
 
• To analyze the phenotype of the pleiotropic factor lin-28 null mutant during 
Drosophila development 
 
• To determine whether DmMANF is required for the maintenance of the 
dopaminergic system in the fly pupal and adult brain 
 
• To characterize and investigate the mode of appearance of an unusual cell type in 
the Drosophila brain 
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MATERIALS AND METHODS 
Materials and methods used in this work are described in detail in the original articles and 
manuscripts. 
Table 1. Methods 
Method Article 
Fly genetics 
Crosses I, II, III, IV 
RNAi  III, IV 
Tissues of interest 
Pupal / Adult brain I, III, IV 
Ovary II, III 
Muscle II, III 
Nephrocyte III 
Testis III 
DNA and RNA methods 
PCR II 
mRNA In situ hybridization I 
Immunological methods 
Western blotting III 
Immunohistochemistry II, III, IV 
Lysotracker staining III 
Microscopy 
Bright Field Microscopy I, II, III, IV 
Fluorescent Microscopy II, III, IV 
Confocal Microscopy II, III, IV 
Transmission Electron Microscopy III 
Behavioral studies 
Negative Geotaxis II 
Spontaneous Locomotion Activity Assay II 
Induced Locomotion Activity Assay II 
Oviposition Assay II 
Other studies 
BrdU feeding III 
Trauma Induction III 
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Table 2. Fly strains 
Fly strain Code Source Article 
alrm-Gal  (Doherty et al., 2009)  III, IV 
ATM8 #8624 BDSC III 
D/Cyo;Dr/Tm6TbSbYFP  Gift from I. Salecker III, IV 
delDmGfrl  Generated by J. Kallijärvi for I 
da-Gal4  (Wodarz et al., 1995) II, III, IV 
Df(3L)Exel6106 #7585 BDSC II 
DF(3L)ZN47 #3096 BDSC II 
elav-Gal4 #458 BDSC III, IV 
elav-Gal4 #8760 BDSC III, IV 
FRT82B; tubulin-Gal80 #5135 BDSC IV 
Gad1-Gal4  (Ng et al., 2002) IV 
gcm-Gal4  Gift from A.Giangrande III 
He-Gal4, UAS-GFP #8700 BDSC III 
Hml-Gal4, UAS-GFP #30140 BDSC III 
hop2 #6032 BDSC III 
hopTum #8492 BDSC III 
hsFLP #8862 BDSC IV 
Kr/CyO; D/Tb Sb #7199 BDSC III, IV 
lama-Gal4  (Chotard et al., 2005) IV 
lin-28dF30, lin-28dF101  Generated by F. Michon and T. I. Heino for II 
Nazgul-Gal4  Gift from B. Altenhein III 
NP1243 v12835 DGRC III, IV 
NP2222 v112830 DGRC III, IV 
NP2276 v112853 DGRC III, IV 
NP3233 v113173 DGRC III, IV 
NP6293 v105188 DGRC III, IV 
NP6520 v105240 DGRC III, IV 
P{EP}lin-28EP915 #17298 BDSC II 
P{Δ2-3} #3629 BDSC II 
prospero-Gal4  Gift from B. Denholm III 
repo-Gal4  (Sepp et al., 2001)  III, IV 
Sb/TM3 ActGFP Ser #4534 BDSC II 
Stat92EF #24757 BDSC III 
sws4 #28121 BDSC III 
swsolfE-x26 #1015 BDSC III 
tubulin-Gal4  (O'Donnell et al., 1994) IV 
UAS-Atg1[6A]  (Scott et al., 2007) III 
UAS-Atg1[6B]  (Scott et al., 2007) III 
UAS-Atg1[GS10797]  (Scott et al., 2007) III 
UAS-Atg1K38Q[5B]  (Scott et al., 2007) III 
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Table 2 continued… 
 
Fly strain Code Source Article 
UAS-DIAP1 #6657 BDSC III 
UAS-Dicer-2  (Baumgardt et al., 2007)  III, IV 
UAS-DmMANFRNAi v12834 VDRC III 
UAS-DmMANFRNAi v12835 VDRC III, IV 
UAS-grim,  (Zhou et al., 1997) III 
UAS-hid, -rpr (,-grim)  (Zhou et al., 1997) III 
UAS-Hsap\SNCA.A30P #8147 BDSC III 
UAS-lacZ  (Brand and Perrimon, 1993) III 
UAS-let-7 #41171 BDSC II 
UAS-Manf135  (Palgi et al., 2009) III, IV 
UAS-mCD8::GFP #5137 BDSC III, IV 
UAS-NeuroglianRNAi v107911 VDRC III 
UAS-nGFP #4775 BDSC II, III, IV 
UAS-p35 #5072 BDSC III 
UAS-p35 #5073 BDSC III 
UAS-PGRC-LC #33917 BDSC III 
UAS-PGRC-LE #33054 BDSC III 
UAS-RelD  Gift from S. Cherry III 
UAS-STATRNAi v100519 VDRC III 
UAS-TefuRNAi v100008 VDRC III 
UAS-Toll #30900 BDSC III 
UAS-Toll #30901 BDSC III 
UAS-TorTED #7013 BDSC III 
UAS-zfh1RNAi v109931 VDRC III 
w1118  Umea Stock Center I, II, III, IV 
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Table 3. Antibodies 
Antigen Name Source/Reference Article 
BAM  DSHB II 
BrdU  GE Healthcare III 
Bruchpilot nc82 DSHB III, IV 
Caspase-3  Cell Signaling Technology II, III 
chaoptin 24B10 DSHB IV 
discs large 4F3 DSHB III, IV 
DmMANF  (Palgi et al., 2009) III, IV 
DNP  ICN ImmunoBiologicals III 
Draper (mouse)  (Freeman et al., 2003) III 
Draper (rat)  (Manaka et al., 2004) III 
dSTAT  (Flaherty et al., 2010) III 
Ecdysone Receptor DDA2.7 DSHB III 
E-Cadherin DCAD2 DSHB II 
elav  DSHB III, IV 
engrailed/invected  DSHB III 
Fasciclin 2 1D4 DSHB III, IV 
Fasciclin 3 7G10 DSHB III, IV 
Hts-RC  DSHB II 
Lysotracker  Molecular Probes III 
Neuroglian BP104 DSHB III 
orb 4H8 DSHB II 
Phalloidin  Sigma II, III 
phospho-Histone 3  Upstate Cell Signalling Solutions II, III 
Relish-C  DSHB III 
Relish-N  Gift from S. Stöven III 
repo  DSHB III, IV 
Spectrin  DSHB II 
Single-minded  DSHB III 
TH  DiaSorin III, IV 
Twinfilin  (Wahlström et al., 2001) III 
Zfh-1  (Postigo et al., 1999) III 
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RESULTS AND DISCUSSION 
DmMANF expression in the adult CNS (III-IV) 
To address how DmMANF is expressed in the adult brain, we performed co-localization 
studies. We found that DmMANF is more widely expressed in the adult brain than in 
embryonic and larval CNS. In the adult brain, DmMANF, apart from co-localizing with 
glial cell bodies, it is also localized with glial processes (IV) (Table 4). We further 
analyzed DmMANF localization and we found that DmMANF is localized in cell bodies 
and processes of all glial subtypes (IV) [as classified by (Awasaki et al., 2008; Doherty et 
al., 2009)]. In addition and contrary to the embryonic expression, DmMANF is also 
localized in neurons, as indicated by co-localization studies when using the pan-neuronal 
driver elav-Gal4 (IV). Interestingly, in adults DmMANF is also localized in the cell somas 
of dopaminergic neurons, but not in their processes, even when DmMANF was 
overexpessed using a dopaminergic driver TH-Gal4 (IV). 
Because DmMANF is a secreted protein, we wanted to investigate whether 
DmMANF labeling in glia and dopaminergic neurons is due to DmMANF being 
expressed cell-autonomously by these cells or not. First, we knocked down the DmMANF 
mRNA by employing the RNAi technique coupled with the upstream activating sequence 
(UAS)/Gal4 system (Dietzl et al., 2007). We tested the RNAi construct by expressing it 
ubiquitously and found that the da-Gal4; UAS-DmMANFRNAi UAS-Dicer-2 larvae died as 
young larvae, phenocopying the DmMANF null mutant phenotype (III). In addition, we 
verified the specificity of the RNAi construct with Western blot (III).  
Next, we knocked down DmMANF specifically either in glia or in neurons by using 
RNAi. In this case, DmMANF was not detected in the cells that the UAS-DmMANFRNAi 
construct was expressed (IV). Secondly, to conditionally knock-out the DmMANF gene in 
the brain we created homozygous DmMANF deficient somatic clones in the adult brain of 
an otherwise wild type animal. In addition, we used the MARCM technique (Wu and Luo, 
2007), which allows the visualization of single cells by generating a labeled homozygous 
mutant clone. In both cases, we never detected DmMANF in DmMANF-/- cells (IV). 
Based on these results, we conclude that DmMANF is actually expressed in both glia and 
in neurons during pupal and adult stages.  
DmMANF expression in the adult non-neuronal tissues (III) 
Immunohistochemical analysis showed that in adult flies, DmMANF is strongly expressed 
in abdominal nephrocytes, in follicle cells and border cells of the ovary and in investment 
cone bundles of testis. Furthermore, DmMANF is not expressed in muscles.  
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Table 4. Driver lines with which DmMANF co-localizes. 
 
Expression Stock name DmMANF expression 
G
lia
l 
Pan-glial  repo-Gal4 Yes 
Astrocyte-like NP1243 * Yes 
Astrocyte-like NP3233 Yes 
Astrocyte-like alrm-Gal4 Yes 
Cortex NP2222 Yes 
Enseathing  NP6520 ** Yes 
Subperineurial NP2276 Yes 
Perineurial  NP6293 Yes 
N
eu
ro
na
l Pan-neuronal elav-Gal4 Yes *** 
Dopaminergic TH-Gal4 Yes *** 
Neurites BP104 & Fasciclin 2 antibodies No 
 
* Has secondary expression in Ensheathing and Cortex glia 
** Has secondary expression in Cortex glia 
*** Only at cell bodies 
DmMANF in vivo functional studies with focus to the dopaminergic system (IV) 
Initially, we wanted to investigate what is the function of DmMANF in the pupal and 
adult brain, and more specifically to examine whether DmMANF is required for the 
maintenance of the dopaminergic system during these developmental stages. In order to 
study the function of DmMANF in later developmental stages, we employed techniques 
that enabled us to bypass the larval lethality of the DmMANF null mutant. These 
techniques included clonal analysis, RNA interference (RNAi) and overexpression studies. 
DmMANF overexpression does not affect the dopaminergic system (IV) 
First, we assessed whether overexpression of DmMANF affects the overall structure of the 
dopaminergic network. We expressed a UAS-DmMANF construct using a variety of 
ubiquitous, neuronal and glial drivers (Table 5). In all cases, the animals appeared to 
develop normally and they eclosed to adulthood. In addition, based on 
immonhistochemistry, their dopaminergic system seemed unaffected. 
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Table 5. Driver lines used in DmMANF overexpression studies to test whether the 
DA system is affected. 
 
Expression Is DA system affected? 
Ubiquitous 
daughterless-Gal4 No 
tubulin-Gal4 No 
Neuronal 
elav-Gal4 No 
Gad1-Gal4 No 
TH-Gal4 No 
Glial repo-Gal4 No 
DmMANF is not required in a cell autonomous fashion for the survival and 
differentiation of the main cell types of the brain (IV) 
We created MARCM clones of the cell types that DmMANF is expressed, namely glia and 
dopaminergic neurons, by using the pan-glial driver repo-Gal4 and the dopaminergic 
specific driver TH-Gal4 lines respectively. In this case as well, although DmMANF was 
knocked out, both glia and dopaminergic neurons developed in the adult brain. In addition, 
both glia and dopaminergic neurons appeared to have a normal morphology and acquired 
their typical positions in the Drosophila brain. Based on the above results, we concluded 
that DmMANF is not required in a cell-autonomous fashion for the survival and 
differentiation of either glia or dopaminergic neurons in the Drosophila brain. 
DmMANF requirement for the development of the dopaminergic system after larval 
stages remains inconclusive (IV) 
According to our co-localization studies, DmMANF is expressed in glial cells and in 
dopaminergic neurons. Consequently, we wanted to see if the dopaminergic system was 
affected when DmMANF is silenced in those cell populations where DmMANF is 
expressed in the adult brain. Flies from three time points [late pupation (dark pupae) and 
1, 10 and 30 days after eclosion] were subjected to confocal microscopy to assess their 
dopaminergic network.  
First, we concentrated on the effect of DmMANF knockdown in neurons and in 
dopaminergic neurons. We used the pan-neuronal driver elav-Gal4 as well as the 
dopaminergic specific driver TH-Gal4 to express the UAS-DmMANFRNAi transgene. In 
both cases, the animals eclosed to adulthood, lived for at least 30 days and we did not 
observe any dramatic locomotion difference when compared to control flies. In addition, 
staining with TH antibody showed that their dopaminergic system was not affected. Next, 
we knocked down DmMANF specifically in glial cells. In this case as well, the animals 
developed normally and did not show any dramatic locomotion defects. In addition, based 
on TH stainings, their dopaminergic system looked unaffected. This result is surprising 
RESULTS AND DISCUSSION 
27 
 
because in DmMANF null mutants the embryonic and early larval dopaminergic neurites 
are seriously affected (Palgi et al., 2009). We reasoned that this discrepancy could be due 
to RNAi being less effective compared to the null mutant situation. Therefore, we tried to 
enhance the RNAi effect, by concurrent Dicer-2 overexpression. Dicer-2 is the limiting 
factor of the RNAi machinery, and concurrent expression of Dicer-2 along with the 
expression of an RNAi construct is an approach commonly used in Drosophila for 
enhancement of the RNAi efficiency (Dietzl et al., 2007). Our results indicated that the 
dopaminergic system was not affected when elav-Gal4 was used. However, when we 
expressed the UAS-DmMANFRNAi UAS-Dicer-2 transgene using the TH-Gal4 construct, 
we observed a significant loss of the dopaminergic system. Interestingly, we observed the 
same phenotype when overexpressing Dicer-2 alone using the TH-Gal4 promoter. It has 
recently been reported by White et al (White et al., 2010), that Dicer-2 expression by the 
TH promoter alone is sufficient to produce a reduction in TH staining. Therefore, our 
results regarding the requirement of DmMANF for the development of dopaminergic 
neurons after larval stages are still inconclusive and require more studies. 
Expression of the UAS-DmMANFRNAi UAS-Dicer-2 transgene under the pan-glial 
driver repo produces a novel phenotype (III) 
Next, we overexpressed the UAS-Dicer-2 construct, while knocking down DmMANF with 
RNAi in glial cells. In this case however, the animals died at different developmental 
stages, depending on the level of the temperature sensitive UAS/Gal4 system expression 
(Duffy, 2002). At temperatures that the UAS/Gal4 system is highly expressed, namely at 
29oC and 25oC, the animals died as third instar larvae. Remarkably, at 29oC, animals 
stayed as 3rd instar larvae an extra 6 days compared to controls and wild type. In addition, 
they exert the same phenotype as described in Iyengar et al. (Iyengar et al., 2011): reduced 
peristaltic contraction frequency and circular path trajectories likely due to loss of normal 
postural control. This phenotype was not characterized further. 
MiCs – Novel cell type (III) 
When we simultaneously knocked down DmMANF and overexpressed Dicer-2 at 18oC, 
animals pupated normally. However, they died as pharate animals and only 3% of them 
eclosed to adulthood. Interestingly, the dopaminergic system of these pharate animals 
seemed unaffected. Strikingly, in the brains of the live pharate animals, an excessive 
number of cells strongly positive for DmMANF appeared in the neuropil areas of the brain 
(Figure 6A and B). Based on this initial observation, we called this cell type Manf 
immunofluorescent Cell (MiC). Neuropils are synapse-dense areas filled with axons, 
dendrites and glial processes and the cell bodies (somas) of neither neurons nor glia are 
known to exist there. This phenotype was fully penetrant since all pupae examined 
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Figure 6. MiCs appear under three different genetic manipulations (see main 
text). (A) In insect brains, the cell somas (both glial and neuronal) are 
predominantly present at the circumference of the brain (dark grey). The central 
part of the brain is synapse-dense and filled with axons, dendrites and glial 
processes. These areas are devoid of cell somas and are collectively called 
neuropils (pale grey). (B) The neuropil organization in repo> UAS-ManfRNAi UAS-
Dicer-2 brains is not disturbed. However, a previously unidentified cell appears, 
we call MiC (white arrows). MiCs are found inside the neuropils. In addition, 
these brains show signs of neurodegeneration (vacuoles) in the first optic chiasm 
(white speckles indicated by a triple arrow). (C) Summary of the main findings: 
MiCs apperar in the pupal brain, when specifically in glial cells either (i) 
immunity or (ii) autophagy or (iii) concurrent DmMANF knockdown and Dicer-2 
overexpression are induced. MiCs express the transcription factor Zfh1 and have 
nuclearly accumulated dSTAT and Relish. In addition, they express the 
transcription factors Engrailed and Single Minded, the conserved neurotrophic 
factor DmMANF and the engulfment receptor Draper. MiCs are loaded with 
lysosomes with multilamellar structures as seen in human lysosomal storage 
disorders. 
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manifested this phenotype (n>300). Staining with the synaptic markers nc82 and Discs 
large (Dlg) revealed no staining at the sites where MiCs were located, therefore indicating 
that MiCs reside in a distinct area in the neuropil. MiCs had elongated arms, indicating 
that they are migratory and they were found in great numbers both besides the central 
brain also in the ventral nerve cord. Interestingly, we did not find MiCs in non-neuronal 
tissues such as muscles (>2 hour old animals), testes and ovaries (>3 day old animals). 
MiCs appeared only when DmMANF expression was downregulated concurrently 
with Dicer-2 overexpression and under the pan-glial promoter repo-Gal4. MiCs did not 
appear when we expressed either UAS-MANFRNAi or UAS-Dicer-2 independently in glial 
cells. This difference can be due to either the lower efficiency of DmMANF alone, or the 
synergistic effect of Dicer-2 upregulation and DmMANF downregulation. In addition, 
MiCs did not appear in the brain when UAS-MANFRNAi and UAS-Dicer-2 constructs were 
expressed either individually or concurrently in neuronal cells under the pan-neuronal 
promoter Elav or the TH specific driver (see above), or other drivers, such as subglial 
specific drivers. Furthermore, MiCs did not appear when we overexpressed UAS-Dicer-2 
along with other RNAi constructs, such as UAS-Zfh1RNAi or UAS-tefu1RNAi under the glial 
promoter repo-Gal4. These data collectively point towards the MiC phenotype being a 
result of synergistic effect of Dicer-2 upregulation and DmMANF downregulation in glia 
cells. 
MiCs do not express the glial marker repo or the neuronal marker elav (III) 
Cell bodies in neuropil areas of the Drosophila brain have not been described in 
bibliography before; therefore, we decided to further investigate the mode of appearance 
as well as the function and origin of MiCs. The Drosophila adult and late pupal brain are 
anatomically similar and they are composed of two main cell types, neurons and glia, 
which are detected by the pan-neuronal marker Elav and the pan-glial marker Repo, 
respectively. Surprisingly, MiCs do not express either of these markers. In order to 
investigate the possibility that MiCs are transdifferentiated glia, we expressed UAS-
MANFRNAi UAS- Dicer-2 UAS-nGreen Fluorescent Protein (GFP) (or UAS-mCD8::GFP) 
using repo-Gal4. This construct enabled us to label with GFP the cells that either 
transiently or constitutively express Repo. MiCs appeared in the induced brains but were 
not positive for GFP, while glia expressed GFP as expected. This indicates that MiCs do 
not express Repo at any point during their differentiation. In spite of this evidence, we 
were not able to conclusively exclude the cell autonomous model for MiC induction, as 
the half-life of GPF has not been studied, and it may degrade during a long time period. 
Do Mics derive from midline glia? (III)  
In the developing Drosophila, there is a single class of glia that does not express Repo. 
This glial class is called midline glia and originates from the mesoectoderm, in contrast to 
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all other glial subtypes that originate from the neuroectoderm. However, midline glia are 
not known to exist in mid- and late pupae. During normal development they are eliminated 
by apoptosis in two temporally distinct waves during embryogenesis and mid-pupation, by 
a process that is regulated by the ecdysone (Rusconi et al., 2000). Interestingly, MiCs 
express the midline specific transcription factor Single-minded (Crews et al., 1988). This 
result raises the possibility that MiCs are midline glia that do not undergo apoptosis, but 
instead survive and migrate to the neuropils. In order to test this hypothesis, we expressed 
either of the two the anti-apoptotic genes p35 or DIAP1 under the midline glia driver 
Single-minded-Gal4. However, in either case MiCs did not appear, indicating that 
inhibition of apoptosis of midline glia is not sufficient for the appearance of MiCs and also 
that glial contribution is necessary for the manifestation of the phenotype. In addition, 
MiCs do not express a second midline specific marker Slit (Rothberg et al., 1990), while 
they express the transcription factor Engrailed, which is known not to be expressed in 
midline glia (Kearney et al., 2004). Together, these data point towards MiCs not deriving 
from midline glia. 
Evidence that MiCs are motile (III) 
The appearance of MiCs in neuropil areas of the brain that are void of cell somas is a 
strong indication that they are motile. In addition, morphological features, such as 
elongated cytoplasmic arms also point towards this direction. Unfortunately, it is not 
technically possible to perform live imaging in Drosophila pupal brain in order to confirm 
their motility. The transcription factor dSTAT is known to specify and maintain cell 
motility in various models of cell migration in Drosophila, including border cell migration 
(Silver and Montell, 2001), germ cell migration (Xi et al., 2003) and migration of 
embryonic tracheal cells (Li et al., 2003). We found that dSTAT is expressed in MiCs and 
is localized in the nuclei, which is a hallmark of the JAK/STAT pathway activation 
(Agaisse et al., 2003). MICs also express the transcription factor Zfh1 which is a known 
downstream target of the JAK/STAT pathway (Leatherman and DiNardo, 2008).  
Induction of immunity in glia also results in the appearance of MiCs (III) 
We further investigated whether the appearance of MiCs is exclusively a 
DmMANF/Dicer-2 related phenotype or does it also appear under other genetic 
backgrounds. It is well documented that the JAK/STAT signaling pathway is involved in 
hematopoiesis and immune response both in Drosophila and in mammals [reviewed in 
(Agaisse and Perrimon, 2004)]. Consequently, in Drosophila Zfh1 has been implicated in 
the Imd pathway activation (Kleino et al., 2005; Myllymäki and Rämet, 2012), in 
hemocyte development in embryos (Frandsen et al., 2008) as well as to inhibit apoptosis 
in a subtype of embryonic subperineurial glia (Ohayon et al., 2009). Therefore, we 
investigated whether the artificial induction of the immune response in glia results in the 
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appearance of MiCs. We activated the two pathways that are responsible for innate 
immunity in flies, namely the Toll and the Imd pathway, by overexpressing either the Toll 
receptor, or the PGRP-LE (-LC) receptor, respectively in glia. We found that MiCs 
appeared when activating the Imd pathway, but not when activating the Toll pathway. In 
addition, when we overexpressed either receptor in neurons, no MiCs appeared, further 
indicating that the MiC phenotype is associated with glial behavior.  
Consistent with the activation of the Imd pathway, in the repo-Gal4; UAS-
DmMANFRNAi UAS-Dicer-2 pupae we found that the NF-κb transcription factor Relish is 
expressed in MiCs and it is accumulated in their nuclei. Relish is the key factor in the 
induction of the humoral immune response in Drosophila and is downstream of the Imd 
pathway, therefore implying that the immune response is activated in MiCs. Based on our 
confocal studies, we detect anti-Relish staining in the nuclei of MiCs with antibodies that 
recognize either the N- or the C- terminus of Relish protein. This result challenges 
previous observations that after cytoplasmic cleavage, it is the N-terminal part of the 
protein that translocates into the nucleus to act as transcription factor, while the C-terminal 
part stays in the cytoplasm (Stöven et al., 2000). However, in these studies, the Imd 
response was triggered by bacterial infections, while in our study, the humoral response is 
triggered by genetic means. In addition and in agreement with our data, a recent study 
where the Imd pathway was triggered by genetic means, an antibody that detects the C-
terminus of Relish was also detected in the nuclei of cells in Malpighian tubules (Tapadia 
and Verma, 2012). However, the authors do not comment on this result in their article.  
MiCs express the engulfment receptor Draper (III) 
Various cues, and most importantly the unexpected appearance of MiCs in the brain when 
brain homeostasis is disturbed, suggest that MiCs resemble mammalian microglia cells. 
Microglia are the dedicated macrophages of the mammalian brain that upon trauma 
infliction, infection or neurodegeneration invoke immune response by secreting 
antimicrobial peptides and by phagocytosis. However, in Drosophila, microglial or 
microglia-like cell population has not been identified. Instead, a number of studies have 
shown that during both development and adulthood, the resident sessile glial population 
assumes a semi-professional macrophagocytotic role (Kurant et al., 2008; Freeman et al., 
2003; Awasaki and Ito, 2004; Tasdemir-Yilmaz and Freeman, 2014; MacDonald et al., 
2006). During this process glia start to express the engulfment receptor Draper (Logan et 
al., 2012; Freeman et al., 2003; Kurant et al., 2008; MacDonald et al., 2006; Tasdemir-
Yilmaz and Freeman, 2014; Manaka et al., 2004). Draper is homologous to the C. elegans 
cell corpse engulfment receptor ced-1, as well as to the mammalian Jedi-1 (Carninci et al., 
1996) and MEGF10 genes (Singh et al., 2010). Interestingly, both Jedi-1 and MEGF10 are 
expressed in glia and play a conserved role in their phagocytic activity (Singh et al., 2010; 
Wu et al., 2009; Cahoy et al., 2008). Immunohistochemistry staining revealed that MiCs 
also express Draper, therefore they are potentially phagocytotic.  
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Induction of autophagy in glia also results in the appearance of MiCs (III) 
An exciting feature of the engulfment receptor Draper is its association with autophagy. 
Autophagy is a conserved catabolic process. During autophagy the cell degrades its 
cellular components using the lysosomal machinery. In Drosophila, it has been shown that 
autophagy has two roles in respect to cell integrity (McPhee et al., 2010). In one case, 
autophagy can be related to survival of the cells. In Drosophila larvae that have been 
starved, autophagy is induced in the fat body as a mechanism for catabolic degradation of 
cellular components. In a second case, during pupal histolysis, autophagy is used as a 
mean of PCD for the degradation of the salivary glands. Interestingly, Draper is cell-
autonomously required for autophagy in dying cells but not in autophagy related to cell 
survival (McPhee et al., 2010). These studies support the earlier studies that have 
proposed the autophagy as a PCD mechanism that is independent of apoptosis and has 
been also named as PCD II (Tsujimoto and Shimizu, 2005; Schwartz et al., 1993; Datan et 
al., 2014). However, the role of autophagy as a means of PCD is still under debate. 
To test if there is a link between MiCs and autophagy, we expressed Atg1 (Scott et 
al., 2007) or the dominant-negative form of Target of rapamycin (TorTED) (Scott et al., 
2004) in glia. In both cases MiCs appeared, therefore recapitulating the phenotype with a 
third evolutionarily conserved genetic approach. In addition, as with the UAS-
DmMANFRNAi UAS-Dicer-2 construct and the immune induction, induction of autophagy 
in neurons did not produce MiCs. Interestingly, the Imd pattern recognition receptor 
PGRP-LE has been shown to trigger autophagic response (Yano et al., 2008), while 
upregulation of autophagy has been observed in a number of lysosomal storage disorders 
(LSDs) (Settembre et al., 2008bb; Settembre et al., 2008aa). 
In our perception, the fact that inducing either autophagy, or immunity or 
downregulating the neurotrophic factor DmMANF specifically in glia cells results in a 
common phenotype is intriguing. Interestingly though, recent studies indicate that 
immunity, autophagy and neurodegeneration share common pivotal genes (Levine et al., 
2011; Levine and Kroemer, 2008; Chang and Neufeld, 2010). These observations come 
mainly from the results of genome-wide association studies (Palgi et al., 2012; Petersen et 
al., 2012; Yano et al., 2008). This phenotype could very well be a striking example of 
crosstalk among these three evolutionarily conserved mechanisms.  
MiCs are rich in lysosomes (III) 
The fact that MiCS express the phagocytotic marker Draper raises the exciting possibility 
that MiCs perform phagocytosis. In order to investigate this hypothesis, we performed 
electron microscopy to gain insights about the ultrastructure of MiCs. 
Toluidine blue is a dye with high affinity for acidic molecules and is the standard 
dye used in transmission electron microscopy to visualize cells in semithin sections before 
the actual thin-sectioning. In these sections scattered cells that were stained strongly 
purple were located in neuropil areas. This pattern was highly reminiscent of the 
distribution of MiCs in confocal sections. Such cells were not seen at all in section of the 
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control brains. In parallel we exposed repo-Gal4; UAS-DmMANFRNAi UAS-Dicer-2 brains 
to DAMP [N-{3-[(2,4-Dinitrophenyl)amino]propyl}-N-(3-aminopropyl)methylamine, 
dihydrochloride], which is used to detect acidic organelles, such as lysosomes (Anderson 
et al., 1984). DAMP can be recognized with anti-Dinitrophenol (DNP). These brains 
unlike control brains had numerous cells in the brain neuropil areas positive for DNP and 
they co-localized with MiC markers. Staining with the lysosomal marker Lysotracker, 
revealed that brains from repo-Gal4; UAS-DmMANFRNAi UAS-Dicer-2 animals were 
positive also for this lysosomal marker, again the control brains that were negative. Based 
on these results, it can be concluded that the cytoplasm of MiCs is highly acidic and that 
they are rich in lysosomes. 
Transmission electron microscopy identified cells in the neuropil areas of the brain 
with dramatic morphology. These cells had intact nuclei, indicating that they were not 
undergoing apoptosis, while their cytoplasm was filled with lysosomes. The lysosomes 
were exceptionally large with highly electron dense, transversely stacked membranes. 
These lysosomes strongly resemble the typical morphology of lysosomes as seen in 
human LSDs (Burton et al., 2012). Further investigation revealed that in flies, there are 
several models of LSDs and one them is caused by Saposin (dSap-r) deficiency (Hindle et 
al., 2011). Interestingly, according to crystallography studies, the N-terminal domains of 
both Manf and CDNF have saposin-like lipid-binding domains (Parkash et al., 2009). 
However, contrary to our initial hypothesis, we never showed signs of endocytosis in 
MiCs, such as membrane internalizations or cellular debris.  
MiCs induced by any of the three genetic manipulations express the same markers 
(III) 
As shown above MiCs appear in the neuropil areas of the pupal brain, as a result of three 
different genetic manipulations: (i) by the concurrent downregulation of the neurotrophic 
factor DmMANF, and by the induction of either (ii) immunity or (iii) autophagy in glia. 
Based on our results, the cells appearing under all three different genetic manipulations are 
the same cell type. In all three cases, the induced cells express the conserved neurotrophic 
factor DmMANF, the engulfment receptor Draper, and possess nuclear localization of 
transcription factors Zfh1, dSTAT and Relish. In addition, in all three cases, MiCs do not 
express the neuronal marker Elav or the glial marker Repo. Furthermore, in all cases, these 
brains, unlike the control brains, are positive for the lysosomal marker Lysotracker. In 
conclusion, the cells that appear in the neuropil areas of the brain under any of the three 
genetic manipulations are of the same cell type (Figure 6C). 
MiCs appear during early pupation and do not divide (III) 
A key question in understanding the origin of MiCs is at what developmental stage they 
appear. We never saw DmMANF+/Zfh1+ cells in the neuropils of larvae. We were able to 
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first identify DmMANF+/Zfh1+ in the neuropils of 32.5 hours after puparium formation 
(APF) pupae. The number of MiCs increased greatly at around 80 hours APF, which 
coincides with the increase in the volume of neuropils. The greatest number of MiCs is 
found during late pupation (~99 hours APF) or just before the animals die. All late pupae 
tested at 99 hours APF were alive, as they were moving their legs and proboscis upon their 
removal from the pupal case. Surprisingly, the ~3% of animals that survived to adults, 
lived to at least 15 days and they appeared to have very little or no MiCs. Interestingly, 
MiCs were not positive for cleaved Caspase-3, indicating that MiCs do not undergo 
caspase-dependent apoptosis during late pupal stages. 
Consequently, we wanted to investigate whether MiCs divide during pupation or 
they originate from a still unidentified location from which they migrate. First, we stained 
with the mitotic marker phosphorylated Histone 3 (PH3) the brains of 80 hours APF 
repo>UAS-ManfRNAi UAS-Dicer-2. PH3 is an M phase marker of the cell cycle. We never 
saw MiCs being PH3 positive. Next, we used the synthetic thymine analogue BrdU (5-
bromo-2’-deoxyuridine) to perform a BrdU pulse/chase experiment (Boone and Doe, 
2008). Late 2nd / early 3rd instar larvae were fed with BrdU for 3 hours and then they were 
allowed to develop without BrdU until they reached late pupation (more than 100 hours 
after the feeding). Interestingly, at 99 hours APF all MiCs were positive for BrdU. This 
result suggests that MiCs divide during late 2nd / early 3rd instar larvae as they 
incorporated the BrdU. However, after this initial division(s), MiCs do not divide, or they 
divide at low rates resulting in the BrdU not to be diluted out, but to be maintained in all 
MiCs found in the neuropil. The PH3 and the BrdU pulse/chase experiments collectively 
suggest that MiCs do not divide (or divide at a very low rate) during pupation. 
The critical developmental time for MiC induction is first and second instars (III) 
A second key question in understanding the origin of MiCs is at what time during 
development do glia cells need to be manipulated in order to produce MiCs in the pupal 
brains. In order to answer this question, we took advantage of the temperature sensitivity 
of the UAS/Gal4 system (Duffy, 2002) and the higher permissive temperature of the 
repo>UAS-TORTED animals. We shifted animals between a temperature that the UAS-Gal4 
system activity is significantly decreased (19oC) and a temperature that the UAS-Gal4 has 
high activity (26oC). We found that raising repo>UAS-TORTED animals at 26oC during 
either second or third instar larval stage was sufficient for MiCs to appear, irrespective of 
what temperature the rest of their development occurred. Therefore, we can conclude that 
the critical time for glia manipulation in order to produce MiCs in the pupal brain is 2nd 
and third instar larvae. Combining this result with the BrdU pulse/chase and PH3 results, 
we propose that MiCs originate from cell precursors that divide during 2nd / 3rd instar 
larva, which they subsequently stop dividing and they are invading the neuropil areas 
during pupation. Interestingly, these non-dividing cells are long living cells, as they are 
not caspase-3 positive during late pupation (live more than 100 hours long). 
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MiCs do not appear under other conditions tested (III) 
We further explored if there would be other contexts where MiCs could appear. These are 
summarized in the Supplementary Table S1 of article III. One hypothesis we investigated 
was whether MiCs appear in fly neurodegeneration models. In tissues from patients with 
chronic neurodegeneration diseases, active microglia exists in large numbers (Perry et al., 
2010). To test this hypothesis we used the alpha-synuclein model of Drosophila 
Parkinson’s disease (Feany and Bender, 2000), the swiss cheese (Kretzschmar et al., 1997) 
and the ATM8 (Petersen et al., 2012) neurodegeneration models. Due to the onset of 
neurodegeneration in these models [alpha-synuclein model, adult (Feany and Bender, 
2000); ATM8 model, day 7 post eclosion (Petersen et al., 2012)], we tested for MiCs at late 
pupal stage, as well as in 10-day-old flies. However, in none of the cases we observed 
MiCs. This result can be explained due to the late onset of the disease in these models 
which show no signs of neurodegeneration during pupation and this is the reason that no 
MiCs appear. 
In mammals, microglia activation is also induced by trauma induction. We induced 
traumatic brain injury in the brain of 4-day-old Drosophila by using a model developed by 
Leyssen (Leyssen et al., 2005). Briefly, heads from newly eclosed flies were pierced by 
inserting a thin needle below the left antenna, through the left optic lobe. Flies were then 
left to recover for 4 days, prior to dissection. However, in this instance as well, MiCs did 
not appear. Again, the reason is possibly due to the use of adult animals. Unfortunately, 
inducing brain trauma in Drosophila during pupation is not feasible with current tools. 
MiCs are macrophage-like cells (III) 
Although microglia-like elements have been identified in the ganglia of other 
invertebrates, microglia or microglia-like cells have never been reported in Drosophila. 
Instead, it has been shown that sessile glia assume the role of the immune-associated cell 
type in the fly brain during development (Tasdemir-Yilmaz and Freeman, 2014; Kurant et 
al., 2008; Awasaki and Ito, 2004; Freeman et al., 2003) and during adulthood (MacDonald 
et al., 2006).  
Our data suggests that MiCs are macrophage-like cells and they share similarities to 
mammalian microglia. First, as during microglia activation, MiCs arise when brain 
homeostasis is disturbed. In addition, MiCs are likely to be motile and they are only found 
in the CNS and ventral nerve cord, and not in any other tissues examined. MiCs express 
the pro-inflammatory mediator Relish, the transcription factor dSTAT and the engulfment 
receptor Draper. They also express neurotrophic factors, such as DmMANF. Interestingly, 
recent studies have shown that MANF is strongly upregulated in activated rat brain 
microglia (Shen et al., 2012). 
An unexpected finding was that MiCs have an extremely high lysosomal content. 
Theoretically, one would expect that a cell type like microglia that is highly phagocytotic 
would have increased capacity to degrade subcellular material through the lysosomal 
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pathway. This could be achieved either by having high lysosomal content, or their increase 
activity or both. Surprisingly, such a relationship between lysosomes and microglia has 
not been documented. In addition, no connection between microglia and autophagy has 
been established. Interestingly, LSDs have been connected with upregulation of autophagy 
(Hindle et al., 2011) and upregulation of innate immunity genes (Alam et al., 2012). 
Are MiCs of hemocyte origin? (III) 
Apart from sessile glia, hemocytes are a second cell type that performs phagocytosis in 
Drosophila (Tepass et al., 1994). However, hemocytes have not been shown to enter the 
brain due to the blood brain barrier. Drosophila hemocytes have been extensively studied 
during embryogenesis and larval stages. Interestingly, they express several markers 
expressed by MiCs, including Zfh1 (Frandsen et al., 2008), Draper (Manaka et al., 2004), 
and they have activated the JAK/STAT pathway (Agaisse and Perrimon, 2004).  In 
addition, in Drosophila, autophagy is induced in hemocytes in response to bacterial 
infections (Yano et al., 2008). Unlike in earlier developmental stages, little is known about 
hemocytes during pupation and adulthood.  
We identified two subpopulations that express either the hemolectin or the hemese 
hemocyte-specific markers in the periphery, but not in neuropils, of late pupal brain with 
non-overlapping expression pattern. Unexpectedly, both subpopulations expressed the 
glial marker Repo. This result is rather confusing as it indicates that both of these cell 
populations are glia rather than hemocytes in the pupal brain. Expression of the UAS-
DmMANFRNAi UAS-Dicer-2 construct by using promoters of either hemolectin-Gal4 or 
hemese-Gal4 did not trigger the appearance of MiCs. These results suggest that MiCs are 
not of the same lineage as hemocytes. Furthermore, MiCs were not induced when gcm-
Gal4 was used. gcm has a role in the differentiation of both glial (Freeman et al., 2003) 
and hemocyte (Vivancos and Giangrande, 1997) lineages. 
Expression of the Drosophila GDNF receptor-like transcript in the adult 
brain (I) 
Using bioinformatic and biochemical analyses a Drosophila gene that encodes a protein 
with four cysteine-rich GFRα domains and a GPI anchoring site was identified. This gene 
was named this gene Drosophila melanogaster Gfr-like (DmGfrl). Further biochemical 
analysis showed that Gfrl is glycosylated, secreted and GPI anchored on the cell surface, 
similarly to mammalian GFRα proteins. Expression studies in the embryos revealed that 
DmGfrl expression starts in the Drosophila nervous system at stage 13, time that coincides 
with the start of neuronal differentiation. Further analysis showed that, at least at the 
embryonic stage, Gfrl positive cells co-localize with neurons and not glia. Also the mRNA 
expression pattern of DmGfrl in relation to DmRet was investigated. We found that during 
embryogenesis, expression of both transcripts coincides temporally. However, based on 
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the in situ analysis, DmGfrl and DmRet expressions do not overlap either during 
embryogenesis or during larval stage. I specifically studied the mRNA expression of 
DmGfrl and DmRet in the adult Drosophila brain. DmGfrl mRNA was abundantly 
expressed in the cell somas of the central brain. Interestingly, this expression pattern 
resembles the GABAB receptor-2 expression in the GABAergic interneurons (Okada et al., 
2009). Surprisingly, no DmRet mRNA expression was detected in the adult brain. Based on 
these findings we hypothesize that unlike in mammals, in the fly DmGfrl and DmRet do 
not interact in cis.  
Isolation of a lin-28 mutant (II) 
Drosophila has a single gene that is homologous to lin-28. It encodes an 195 amino acid 
protein whose amino acid sequence is 57% identical to C. elegans Lin-28 and 47% to 
human Lin-28A proteins. The Berkeley Drosophila Genome Project identified a P element 
insertion that mapped to lin-28’s third intron. This strain, EP(3)0915, is homozygous 
viable, fertile and shows no obvious phenotype. In order to investigate whether this P 
element insertion causes a mutation to the lin-28 gene, we examined whether the let-7 
mRNA levels are affected in this strain. It is well established that let-7 is a highly 
conserved target of Lin-28 (Viswanathan et al., 2008; Piskounova et al., 2011; Zhong et 
al., 2010; Loughlin et al., 2011). Lin-28 protein physically binds to the let-7 precursor, 
resulting in inhibition of let-7 maturation. qPCR showed that in the EP(3)0915 line, let-7 
levels are identical to the levels of wild type, indicating that in the EP(3)0915, let-7 is not 
affected.  
Imprecise P-element excision was used to generate deletions of the lin-28 gene, from 
the EP(3)0915 line. Two hundred lines with potential excision were created, all of which 
were viable and fertile as homozygotes. One line was selected for further studies, hereafter 
referred as lin-28dF30. Sequence analysis showed that the P-element excision in lin-28dF30 
allele caused a deletion of 1 007 base pairs upstream of the original P-element position. 
This predicted that the mutant Lin-28dF30 protein lacks the CSD, the linker and the first 
CCHC domain, while the second CCHC domain would remain unaffected. Combining our 
sequencing results and findings by Nam et al (Nam et al., 2011) that physical interaction 
between Lin-28 and let-7 requires both the CSD and the linker domain, we concluded that 
the lin-28dF30 mutant is a null mutant, at least in respect to its ability to regulate let-7 
mRNA. 
let-7 levels are down regulated in lin-28dF30 mutants (II) 
The mode of action of Lin-28 as inhibitor of microRNA let-7 is evolutionarily conserved 
(Viswanathan et al., 2008; Piskounova et al., 2011; Zhong et al., 2010; Loughlin et al., 
2011). In Drosophila, let-7 is expressed in ovaries (Sempere et al., 2002). On the other 
hand, Lin-28 has been shown to be expressed in mouse (West et al., 2009) and in human 
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(Childs et al., 2012) GSCs [also see review (Spradling et al., 2011)]. We noticed a 
dramatic increase of let-7 levels in lin-28dF30 mutant ovaries. This result shows that the lin-
28 function as a regulator of let-7 is also conserved in Drosophila.  
lin-28dF30 mutant flies have muscular defects (II) 
Previously it has been shown that let-7 is involved in the muscle formation and 
remodeling in Drosophila (Caygill and Johnston, 2008; Sokol et al., 2008). In let-7 
mutants the abdominal dorsal oblique muscles (DIOMs) were retained after eclosion and 
during adulthood (Sokol et al., 2008). Under normal conditions, DIOMs are required for 
eclosion and they are lost 12 hours post eclosion. Therefore, we tested if deletion of lin-28 
and subsequent upregulation of let-7 would result into a phenotype in DIOMs. In lin-
28dF30 mutant animals the DIOMs were missing in pharate animals. This muscular 
phenotype was also demonstrated by behavioral studies that showed that 50% of lin-28dF30 
mutant flies either failed to exit the pupal case or died shortly after eclosion. Both lin-28 
and let-7 are heterochronic genes known to have key roles during cell differentiation, 
tissue growth and organ formation (Moss, 2007). These roles, along with their reciprocal 
inhibitory effect they produce, could explain why the phenotypes observed in the lin-28 
and let-7 mutants have opposite phenotypes, i.e. abnormal number of DIOMs. 
lin-28dF30 mutant ovaries have supernumerary nurse cells (II) 
Lin-28 has been shown to be an important factor in GSC maintenance in mouse (West et 
al., 2009) and human (Childs et al., 2012) ovaries. In addition, the Drosophila let-7 
mutants show decreased egg laying (Sokol et al., 2008), a phenotype that has not been 
further studied. Therefore, we investigated whether lin-28 deletion has also an effect on 
female fertility.  We found that lin-28dF30 mutant flies laid 5 times less eggs compared to 
control flies. Next, we examined whether the reduced fertility is due to abnormalities in 
the oogenesis of lin-28dF30 mutants. We observed that in lin-28dF30 mutant ovaries, in 40% 
of the ovarioles, there was at least one egg chamber that had supernumerary nurse cells. 
We concentrated on later stages of oogenesis, where this phenotype is easier to score due 
to egg chamber size and availability of molecular markers. The number of nurse cells in 
these egg chambers varied from 22 to 47 nurse cells (Figure 7). Such a supernumerary 
phenotype has been described in bibliography before [e.g. maelstrom mutant (Sato et al., 
2011), maelstrom is involved in the Drosophila oocyte axis symmetry]. 
The increased number of nurse cells can be the result of three possibilities. First, the 
neighboring egg chambers may fuse. In this case we would expect the new egg chamber to 
have a number of nurse cells that is multiplication of the number 15 (30, 45 etc.). In 
addition, we would expect that the number of ring canals would equal the number of nurse 
cells. Furthermore, we would expect to see nurse cells grouped together into distinct 
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groups of cells with different dimensions, corresponding to individual cysts within the 
same egg chamber.  
A second possibility is that the increased nurse cell number arises by abnormal 
control of GSC proliferation. In this case, the number of nurse cells in an egg chamber will 
not be a direct derivative of number 15. In addition, the number or ring canals would not 
equal the number of nurse cells (Figure 4C). The third possibility is that the 
supernumerary phenotype is a combined result of the two previous cases.  
Thorough investigation of abnormal stage 9 and 10 egg chambers showed that the 
number of nurse cells is always equal to the number of ring canals. In addition, we 
observed ectopic oocytes in all cases, grouped together with nurse cells of similar size. 
Therefore, we concluded that the supernumerary nurse cell phenotype in lin-28dF30 mutant 
egg chambers is a compound phenotype of egg chamber fusion and mitotic defects 
(Figure 4D), as reported for the maelstrom mutant line (Sato et al., 2011). 
 
 
 
 
Figure 7. Drosophila oogenesis in Lin-28F30 mutants (A) Control 
germaria have 2 to 3 GSCs (green). (B) Control stage 9 egg chambers have 
15 nurse cells (pastel blue) and one oocyte (purple). (C) Lin-28F30 
germaria exhibit increased number of GSCs, compared to controls (A). (D) 
Lin-28F30 stage 9 egg chambers have multiple oocytes (purple), while the 
number of nurse cells is greatly increased compared to controls (B).  
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let-7 overexpression recapitulates the supernumerary egg chamber phenotype (II) 
Lin-28 has been shown to exert large part of its function through inhibition of let-7. The 
increased let-7 levels in lin-28dF30 mutant fly ovaries suggest an interaction of Lin-28 with 
let-7 in oogenesis. In order to test this hypothesis, we overexpressed let-7 specifically in 
ovarian follicle cells, therefore mimicking the Lin-28 depletion in these cells. 
Interestingly, in this case as well, we observed supernumerary nurse cells. This result 
indicates that the supernumerary egg chamber phenotype is, at least partly, the result of 
let-7 overexpression. However, in this case all supernumerary egg chambers had 30 nurse 
cells. This results points towards let-7 overexpression in follicle cells and can only 
account for the egg chamber fusion phenotype, but not for the mitosis defect. 
Supernumerary egg chambers have abnormal EcR and Fasciclin 2 expression 
patterns (II) 
Ecdysone is the most important steroid hormone in flies that regulates various 
developmental decisions. Interestingly, it has been shown that the ecdysone signaling 
regulates let-7 during development (Sempere et al., 2002). In addition, the let-7 target 
Abrupt (Caygill and Johnston, 2008; König et al., 2011) interacts with Ecdysone signaling 
by a negative feedback loop (Jang et al., 2009). Abrupt also represses the expression of the 
cell adhesion molecule Fasciclin 2 in the developing Drosophila brain (Kucherenko et al., 
2012). Therefore, let-7, Ecdysone signaling, Abrupt and Fasciclin 2 constitute a complex 
network that regulates critical developmental decisions, such as border cell migration and 
GCS differentiation (Figure 8A).  
Border cell migration in Drosophila ovaries initiates at stage 9 and it is critical for 
both fertilization of the egg as well as for the dorsal ventral patterning of the anterior-
posterior patterning of the egg chamber (Montell, 2003). Under normal conditions the 
Ecdysone receptor (EcR) is expressed specifically in the anterior follicle cells of stage 9 
egg chambers (Jang et al., 2009). In concert with the Ecdysone receptor (EcR) expression 
timing, ecdysone signaling increases during stage 9 to peak during stage 10 (Schwartz et 
al., 1989). We found that in stage 9 supernumerary lin-28dF30 egg chambers, the EcR 
pattern is not restricted in the anterior follicle cells, but it is uniformly expressed in all 
follicle cells surrounding the egg chamber. Although the precise Ecdysone expression 
pattern is not known, we suggest that the uniform EcR expression pattern in the follicle 
cells of supernumerary lin-28dF30 egg chambers breaks the Ecdysone signaling asymmetry 
that is required for proper oogenesis and initiation of border cell migration.  
Fasciclin 2 is also required for initiation of border cell migration (Szafranski and 
Goode, 2004). It is expressed ubiquitously in follicle cells through stage 7. At stage 8 and 
when border cell start to differentiate, Fasciclin 2 expression is confined in a small cluster 
of cells in the anterior of the egg chamber, known as polar cells. This change in expression 
is critical for the timing of border cell delamination from the epithelium (Szafranski and 
Goode, 2004). Again, in stage 8 supernumerary lin-28dF30 egg chambers we found that the 
RESULTS AND DISCUSSION 
41 
 
Fasciclin 2 expression pattern symmetry is disturbed. In these egg chambers, Fasciclin 2 
expression is not confined only to 2-3 cells at the anterior of the egg chamber. In contrast, 
Fasciclin 2 is expressed broadly at the anterior of the affected egg chamber.  
 
 
 
 
Both the ecdysone-signaling pathway and Fasciclin 2 have important roles in 
various developmental decisions during Drosophila oogenesis. In supernumerary stage 8 
and stage 9 lin-28dF30 egg chambers the tight expression patterns of both the EcR and 
Fasciclin 2 are greatly impaired. In line with observations, we never observed 
supernumerary egg chambers of developmental stage older than stage 10, indicating that 
the supernumerary egg chambers undergo apoptosis during the mid and late oogenesis 
checkpoints (McCall, 2004). In addition, in supernumerary stage 9 and stage 10 lin-28dF30 
egg chambers we never observed border cells. 
Figure 8. Network of key factors involved in GSC differentiation and 
border cell migration in Drosophila (based on bibliography). (A) 
Under normal conditions, let-7 miRNA maturation is under strict control 
of Lin-28. (B) In lin-28 null mutants, this let-7 miRNA maturation 
control is impaired, leading to GSC and border cell migration defects. 
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lin-28dF30 germaria display abnormal GSC differentiation (II) 
In order to investigate the mechanism behind the supernumerary nurse cell phenotype 
observed in lin-28dF30 egg chambers, we focused on GSCs differentiation in germaria. 
Spectrin is a marker for cyst identification (de Cuevas et al., 1996) (Figure 4B). GSCs are 
characterized by a spherical proteinous organelle, called the fusome. The fusome is 
recognized by Spectrin and appears as a round Spectrin accumulation. As GSC divides 
towards cystocytes with incomplete cytokinesis, the cystocytes are interconnected by the 
fusome. The fusome, which derives from the spectrosome is also recognized by Spectrin. 
Therefore, the more differentiated the cystocyte is, the more fusome material will be 
present and the more branched morphology the Spectrin will reveal (de Cuevas et al., 
1996).  
In all control germaria, two rounded fusomes next to the cap cells exist, located at 
the anterior of each germarium, corresponding to the two GSCs. Posteriorly, fusome 
acquired a branched morphology, indicating the cystocyte formation and subsequent 
differentiation. In lin-28dF30 germaria we identified multiple rounded fusomes, 
corresponding to multiple GSCs. Some of the rounded spectrosomes are localized next to 
the cap cells; however, other rounded spectrosomes were located more posterior, to areas 
of the germarium that no GSCs should exist. This result shows that in lin-28dF30 germaria, 
there is an increase of undifferentiated GSCs (Figure 7C). 
To further investigate the GSC differentiation defect of lin-28dF30 germaria, we 
visualized the expression of Bag of Marbles (Bam). Molecularly, Bam is under the strict 
control of Decapentapligic (Dpp) (Chen and McKearin, 2003). Bam is strongly expressed 
in cystoblasts and to a lesser degree to mitotically active cystocytes, while it is not 
expressed in GSCs (Chen and McKearin, 2003). Bam is a direct regulator of the switch 
from stem cell to cystoblast both in Drosophila ovaries and testes. Ectopic expression of 
Bam is sufficient to extinguish stem cell division in the germarium (Ohlstein and 
McKearin, 1997). On the other hand, in Bam mutant ovaries, the proliferating germ cells 
appear to behave as stem cells (Ohlstein and McKearin, 1997), highlighting the 
importance of Bam in the initiation of germ cell differentiation. Interestingly, in lin-28dF30 
germaria we observed that Bam expression is drastically reduced and we did not observe 
any distinctive strong expression at the cystoblasts. This expression pattern shows that in 
lin-28dF30 germaria the Bam-driven initiation of germ differentiation is impaired, result 
that reiterates the increase of undifferentiated GSCs as shown with the Spectrin staining. 
These results combined, strongly indicate that in lin-28dF30 germaria, differentiation of 
GSCs to cystocytes is impaired, resulting to germ cells that are possibly amplifying. It is a 
distinct possibility that the amplifying germ cells actually undergo incomplete cytokinesis 
and progress through the cell cycle within as cyst, as it has been shown to be the case in 
bam mutant testes (Gonczy et al., 1997). 
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CONCLUSIONS 
Our findings provided valuable information on the role of neurotrophic factors in 
Drosophila (I, III, IV). This is particularly interesting when taking into account that 
neurotrophic factors in Drosophila were an elusive topic until very recently. In addition, 
article II describes for the first time the characterization of the reprogramming factor Lin-
28 in Drosophila. 
Article IV describes basic research concerning the characterization and functional 
studies of the novel conserved neurotrophic factor DmMANF. Given that MANF and its 
mammalian ortholog CDNF have both shown to specifically affect dopaminergic neurons 
in vertebrates and in Drosophila embryos, and because human MANF has an orthologous 
function in the fly, the focus of this study was to investigate the role of DmMANF in adult 
flies (IV). To our surprise, these functional analyses did not reveal any obvious effect on 
the dopaminergic system (article IV). Instead we observed the appearance of numerous 
obscure cells in the pupal brain, in areas where no cell bodies are known to exist (III). 
Since this observation was very striking and to our knowledge such a phenotype has never 
been described before, we decided to concentrate exclusively on the analysis of this novel 
cell type (III). The results from the Manf study (article IV) show that DmMANF has a 
wider expression during pupal and adult developmental stages, when compared to 
embryonic expression. However, article IV does not conclusively resolve whether 
DmMANF is required for the support of dopaminergic neurons during adult stages, 
hypothesis that will need further studies to be resolved.  
Article III reports the finding and identification of this novel cell type in the 
Drosophila pupal brain that has not been described previously. We named this cell MiC 
(MANF immunoreactive Cell), based on our initial observation that these cells were 
strongly DmMANF positive. In addition, these results (III) show that this dramatic 
phenotype is manifested by employing three different genetic mechanisms i.e. not only by 
silencing DmMANF but also when either immunity or autophagy is induced. We identified 
molecular markers, pathways activated as well as subcellular features of these cells. 
Importantly, MiCs strikingly resemble mammalian microglia, a cell type that has not been 
described in Drosophila before (III). The results from this study brings new and exciting 
data on glial and brain biology, as well as on the cross talk of three main evolutionarily 
conserved mechanisms, namely autophagy, immunity and neurotrophic factors. Further 
studies could concentrate on the origin of MiCs, their function as well as the molecular 
mechanisms that drive the appearance of these enigmatic cells. 
Article I describes the characterization of the Drosophila Gfrα homolog, casting 
light on the evolutionary aspects of a second family of neurotrophic factors, namely the 
GDNF family ligands. 
In contrast to the studies on the Drosophila CNS and neurotrophic factors, article II 
deals with adult stem cells and the evolutionarily conserved pleiotropic factor lin-28. This 
article shows that the Drosophila lin-28, like its mammalian homolog, is involved in the 
GSC differentiation, therefore we provide valuable insights about the mode of action of 
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both Lin-28 and its partner let-7 miRNA. The results of this study contribute in improving 
our understanding of the pivotal role Lin-28 has in stem cell maintenance and 
differentiation. 
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